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BIASES AND BLIND-SPOTS IN GENOME-WIDE CRISPR-CAS9
KNOCKOUT SCREENS
Merve Dede, M.D., M.Sc.
Advisory Professor: G. Traver Hart, Ph.D.

Adaptation of the bacterial CRISPR-Cas9 system to mammalian cells
revolutionized the field of functional genomics, enabling genome-scale genetic
perturbations to study essential genes, whose loss of function results in a severe
fitness defect. There are two types of essential genes in a cell. Core essential genes
are absolutely required for growth and proliferation in every cell type. On the other
hand, context-dependent essential genes become essential in an environmental or
genetic context. The concept of context-dependent gene essentiality is particularly
important in cancer, since killing cancer cells selectively without harming surrounding
healthy tissue remains a major challenge. The toxicity of traditional cancer treatment
protocols to the normal cells stresses the need for new strategies that can identify and
address the weaknesses specific to cancer cells.

Studies showed that CRISPR monogenic knockout screens can identify
specific processes that cells rely on for growth and proliferation, which is a crucial step
in identifying candidate cancer-specific therapeutic targets. While it is widely accepted
that CRISPR screening is both more specific and more sensitive than previously
established methods, the limitations of this technology have not been systematically
investigated.
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In this dissertation, through several lines of integrated analysis of CRISPR
screen data in cancer cell lines from the Cancer Dependency Map initiative, I will
describe several computational approaches to demonstrate that CRISPR screens are
not saturating. In fact, a typical screen has a ~20% false-negative rate, saturating
coverage requires multiple repeats and false negatives are more prevalent among
moderately expressed genes. I will then introduce a solution to the false negative
problem and describe another method that provides a cleaner analysis of the data,
rescuing the false negatives observed in these screens. Moreover, I will show that half
of all constitutively expressed genes are never observed as essential in any CRISPR
screen. Notably, these never-essentials are highly enriched for paralogs, suggesting
that functional redundancy masks detection of a substantial number of genes. Finally,
I will describe our efforts to investigate functional buffering among approximately 400
candidate paralog pairs using CRISPR/enCas12a dual-gene knockout screening
technology and discuss the paralog synthetic lethal interactions that we have
identified, which have escaped detection in monogenic CRISPR-Cas9 knockout
screens. Collectively, these observations reveal significant biases and blind-spots in
the analysis of CRISPR-based functional genomics approaches and offer new
opportunities for the discovery of novel candidate drug targets.
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Chapter 1: Introduction
1.1 Essential Genes
1.1.1 Gene essentiality in cell lines
The concept of gene essentiality has been a fundamental idea in genetics, with
the ultimate goal of defining a set of genes that are indispensable for life. Therefore,
it is important to make it explicit how essentiality is defined in this study. If we look at
gene essentiality from an organismal level, an organism has all the required set of
essential genes in all tissues. If there is a loss of function in these essential genes,
this may either result in death during organismal development or may prevent the
reproduction and growth of that organism into a sexually mature adult. This definition
of essentiality is rather rigid since some genes might become essential under specific
conditions . It is evident that while there is a strict set of essential genes the loss of
which results in lethality, especially in multicellular organisms, there is also a larger
set of genes that are only required during certain developmental stages or in different
tissue types. For example, the International Mouse Phenotyping Consortium (IMPC)
has conducted a large-scale effort to identify essential genes in mice. By generating
a genome-wide set of gene knockouts in mice, IMPC has identified 410 genes whose
knockout led to an embryonic lethal phenotype (The International Mouse Phenotyping
Consortium et al., 2016). The same study also identified a broader set of 3,326
essential genes to include genes whose loss resulted in a “sub-viable” phenotype
based on observed phenotypes in different tissues. Furthermore, in a study that
focused on 2,700 essential genes in C.elegans, the researchers revealed that post-
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developmental inactivation of 64 genes actually resulted in an increased lifespan
(Curran and Ruvkun, 2007).

In this study, we are looking at gene essentiality at a cellular level and at this
level essential genes can be defined as the genes required for cellular growth and
proliferation and if they are lost, you observe a fitness defect. An alternative concept
that is similar to essentiality is fitness. While gene essentiality is mainly considered at
the individual cell level, fitness is a phenomenon observed in a population, where each
gene has a partial contribution to the overall fitness. Fitness can be defined as the
quantification of the relative proliferation rate of a certain population compared to its
wild type counterpart. This concept was demonstrated in yeast studies, where the
fitness of each deletion strain under a specific condition is compared to the strain
without the deletion under the same environmental condition (Hillenmeyer et al.,
2008). Because fitness is a population level metric, it is possible that genes that cause
reduced fitness cannot be detected within a single generation because they don’t
result in immediate cell death. However, in a heterogenous population which is
monitored over multiple generations, negative selection against genes that show even
mild fitness defects over consecutive generations will be detectable at the population
level, as the cells that carry the fitness defects will drop out from the population over
time (Arun K. Ramani et al., 2012; Zhan and Boutros, 2016). Therefore, within a
population, genes that result in fitness defects can be considered as essential genes.
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1.1.2 Types of essential genes – Daisy model
A very useful model that explains different types of essential genes and serves
as a foundation to many ideas in this dissertation is the Daisy Model of Gene
Essentiality that has been proposed previously (Hart et al., 2015, 2014). In this model,
the essential genes in a cell line or a genetic context is represented by the petals of
the daisy (Figure 1.1). The petals of the flower show overlap to differing degrees but
everything shares a common core set of fitness genes in the middle.

Context A

Context B

Core Fitness
Genes

Context
C

`
Figure 1.1: Daisy model of gene essentiality. Essential genes in different contexts are
represented by the petals of the flower, and all petals share the common core set of essential
genes which are essential across all contexts.
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The core fitness genes shared by all petals represent the universally essential
genes that are expected to be present at all contexts. This model is very helpful for a
couple of purposes. First, it helps to define a set of essential genes that are commonly
essential across every cell line or possible context. These universally essential genes
represent the core cellular machinery of the cell such as transcription, translation, DNA
replication and several other processes required for cellular growth and propagation.
Second, these genes provide a control mechanism to evaluate the quality of a screen
to detect these essential genes, since in every whole genome screen performed, one
should expect to detect all these essential genes. The lack of observation of these
genes as essential would indicate a technical or experimental problem in the screen
and caution needs to be applied during the interpretation of the results.

1.1.3 Context-specific gene essentiality
An important implication of the daisy model is that gene essentiality is not
binary in nature and that it depends on environmental conditions. In the model, we
can observe that even though all petals share a common core set of essential genes,
there are also sets of another group of essential genes called context-essential genes
that become essential only in certain conditions, reflecting the context-dependent
nature of gene essentiality. This phenomenon has been observed in previous studies
in model organisms to identify essential genes. In a landmark yeast study, ~5000
homogenous and ~6000 heterogeneous deletion strains were generated, and after
these strains were exposed to different environmental stress conditions as well as to
hundreds of small molecules, and their fitness phenotypes were measured
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(Hillenmeyer et al., 2008). Strikingly, the researchers observed that among ~6000
deletion strains, 97% showed an essential phenotype indicated by a significant growth
defect when deleted. A similar study in bacteria investigated >10,000 phenotypes
generated by testing ~ 4000 bacterial mutants in more than 300 hundred conditions
(Nichols et al., 2011). This study also showed that many putative non-essential genes
are actually required for growth and observed as essential in at least one of the
environmental conditions tested in the study.

Delineating and differentiating core essential genes from context essential
genes is especially important in understanding pathophysiology of human diseases
especially tissue specific pathologies. In the context of cancer for example,
identification of differentially essential genes in tumor cells but not in surrounding
healthy tissue can ultimately lead to development of highly effective therapeutic
agents with no significant side effects. This posits the need for the identification of
human essential genes.

1.1.4 Human gene essentiality
The identification of essential genes in human cells mainly depends on studies
that monitor genes whose loss creates a growth and proliferation defect phenotype in
human cancer cells lines grown under laboratory conditions for multiple generations.
Even though cancer cells undergo multiple genomic alteration events, the main
machineries that are responsible for growth and proliferation both in cancer cells and
healthy human cells are expected to be the same across both instances. However,
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the main driving motivation for the efforts to identify essential genes in cancer cells
has been to pinpoint the essential genes that are differentially essential in human
cancer cells so that novel therapeutics could be designed to target these cancer
specific dependencies. This notion has been explained in the Daisy Model of gene
essentiality described above (Figure 1.1), with the petals representing cancer specific
essential genes in different cancer types. Even though this concept seems quite
straightforward and easy to grasp, the development of appropriate tools to
systematically assay and evaluate organismal level gene essentiality across the entire
genome has been limited by the technologies available. Some earlier methodologies
include alkylating agent based chemical mutagenesis screens in mice (de Angelis et
al., 2000), insertion of transposable elements in Drosophila genes (Bellen et al., 2004),
utilization of RNAi technology to conduct genome-wide RNAi screens in multiple
organisms (Dietzl et al., 2007; Kamath et al., 2003; Meister and Tuschl, 2004; Moffat
and Sabatini, 2006). Most recently, developments in genome editing by the discovery
of CRISPR-Cas9 system and its application to mammalian cells (Shalem et al., 2014;
Wang et al., 2014) enabled a huge breakthrough in human functional genomics
research by enabling systematic genome-scale approaches to unravel human
essential genes. Some of these advances will be discussed in the next sections.

1.2 Identification of essential genes using RNA
interference (RNAi)
RNA silencing or RNA interference is an essential regulator of gene silencing
in eukaryotic organisms. This pathway was first discovered in plants as an antiviral
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protection mechanism to prevent the organisms from the integration of transposable
elements and RNA viruses (Waterhouse et al., 2001). RNAi regulates gene
expression through specific genes that code for short double stranded RNAs
(dsRNAs) that are precursors for small interfering RNAs (siRNAs). These siRNAs
carry sequence homology to the mRNA transcript that is intended for silencing and
thus determines which transcript will be targeted (Meister and Tuschl, 2004). Besides
this innate mechanism to protect against viruses, it was later shown that exogenous
introduction of dsRNAs is capable of achieving gene expression knockdown first in C.
elegans (Fire et al., 1998) and later in D. melanogaster embryos (Kennerdell and
Carthew, 1998).

1.2.1 Small interfering RNA (siRNA)
Studies about the components of the RNAi mechanism showed that the main
regulators are conserved across multiple different organisms. Small RNAs are
produced in a stepwise fashion by two separate dsRNA-specific RNase-III-type
endonucleases called Drosha and Dicer. During the initial step, Drosha nuclease plays
a role in the nuclear processing of long primary transcripts called pri-miRNA
precursors by cutting and creating overhangs on their stems-loops to create ~70
nucleotide long pre-miRNAs (Lee et al., 2003). After this process, these pre-miRNAs
get transported to the cytoplasm through exportin-5 (Lund, 2004; Yi, 2003). In the
cytoplasm, the pre-miRNAs get cleaved by Dicer to generate ~22 nucleotide long final
products called siRNAs with overhangs on both 5’ and 3’ ends (Bernstein et al., 2001;
Elbashir, 2001). The ribonucleoprotein particles (RNPs) that contain the siRNAs get
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reassembled into a multi-component RNA-induced silencing complex (RISC) that has
sequence-specific nuclease activity (Bernstein et al., 2001; Hammond et al., 2000).
This RISC complex includes the siRNA, Dicer as well as the Argonaute (Ago) protein
in its core which binds tightly to the RNA to unwind the siRNA (Hammond, 2001;
Okamura, 2004). After the assembly of the RISC complex, the single stranded siRNA
within the complex guides it to the target mRNA, which is complementary or nearcomplementary in sequence to the siRNA (Martinez et al., 2002). The target mRNA
then gets cleaved by Ago proteins which results in rapid degradation of the cleaved
mRNA and gene silencing (Meister and Tuschl, 2004; Tuschl et al., 1999; Zamore et
al., 2000).

Using this innate mechanism, researchers discovered that the dsRNA that is
needed for RNAi can be externally introduced into cells in order to achieve gene
knockdown. In model organisms, methods such as direct injection of embryos with
dsRNA (Fire et al., 1998; Kennerdell and Carthew, 1998) and transfection of cell lines
with long dsRNAs (Clemens et al., 2000; Hammond et al., 2000) were applied to
investigate mutant phenotypes. Even though the introduction of these long dsRNAs
was easily accomplished in these model organisms, similar efforts in mammalian cells
have proven to be much more challenging due to the activation of the antiviral immune
response through induction of interferon-linked pathways when dsRNAs longer than
30 nucleotides are used (Rana, 2007). Fortunately, later studies showed that the
shorter 21 nucleotide long synthetic siRNAs are capable of inhibiting expression of
genes in mammalian cells without eliciting cytotoxic immune response (Caplen et al.,
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2001; Elbashir et al., 2001). After these studies, using siRNA became the standard
procedure in functional genomics to provide valuable insights into detection of fitness
genes.

In a landmark pilot study, 21 genes were targeted by 21 nucleotide long siRNAs
to identify essential genes that impaired cellular growth post RNA interference,
showing that siRNA could be used to screen mammalian cells (Harborth et al., 2001).
A later larger scale effort used 5305 siRNAs to study genes necessary for cellular
division in HeLa cells (Kittler et al., 2004). Some of the siRNAs used in this study
targeted proteins that regulate core machineries of the cell and hence showed that
knockdown of these essential ribosomal and proteasomal proteins resulted in a
significant fitness defect in cells.

1.2.2 Short hairpin RNA (shRNA)
One major disadvantage of the siRNA based gene interference is that the
instability of the siRNA limits the utility of this system to transient in vitro studies.
Moreover, the system is problematic for cells with low transfection efficiencies which
results in incomplete transfection and therefore incomplete knockdown. To address
these limitations, short hairpin RNAs (shRNAs) were developed which can be
processed by Dicer to transform into siRNAs. The resulting siRNAs can then bind to
target mRNA through incorporation into the RISC complex. Although the shRNAs can
be transfected into cells like siRNA, creating a stable shRNA cell line is an arduous
and time-consuming task as selection of shRNA positive cells usually takes months.
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Therefore, expression through mammalian expression vectors or for cells that are not
easily transfectable, using adenoviral or lentiviral vectors with shRNA expressing
cassettes and transducing cells with packaged virus are more efficient methods for
successful delivery of shRNAs (Abbas-Terki et al., 2002; Brummelkamp, 2002).
Especially lentivirus mediated shRNA delivery has been shown to enable stable and
long-term gene knockdown in rapidly dividing as well as dormant mammalian cells
(Manjunath et al., 2009).

shRNAs contain a 21-29 nucleotide long siRNA sequence, a loop section, the
reverse complement of the siRNA region and a short terminator sequence. While
shRNAs can be expressed using plasmid based systems using RNa polymerase III
(pol III) promoters without triggering interferon responses, the most widely used pol III
promoters are the U6 promoter and the H1(Brummelkamp, 2002; Kawasaki, 2003;
Lee et al., 2002). During transcription, the shRNA transcripts gets organized in a
hairpin structure by folding on itself and gets processed by Dicer (Dykxhoorn et al.,
2003).

1.2.3 Functional genetic screens using RNAi technology
Some of the initial loss of function shRNA screens were conducted in a pooled
format. In pooled loss of function screens, the plasmids containing the shRNA library
gets packaged into lentiviral vectors and then the lentiviral stocks are transduced into
cells using a low multiplicity of infection (MOI) to prevent multiple viral integrations per
cell. The cells that are transduced are selected using an antibiotic selection and are
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grown for multiple doublings under a specific condition. At each passaging time point,
cells are frozen in order to extract shRNA sequences at the end of the assay so that
the relative abundance of the shRNA populations can be quantified compared to the
initial time point using next generation sequencing (Luo et al., 2008). This pooled
screening methodology has been extremely useful for the identification of essential
genes in a systematic way as the shRNAs targeting essential genes are expected to
be depleted from the population over time. One study used an RNAi library with 23,742
unique shRNAs targeting 7,914 different human genes for knockdown in order to
identify regulators of p53 dependent proliferation arrest (Berns et al., 2004). When the
RNAi Consortium (TRC) was founded, an initial TRC library was constructed targeting
both mouse and human genes to determine essential genes for mitotic progression
and proliferation (Moffat et al., 2006). Later, a more extensive version of the TRC
library that included 170,000 shRNAs targeting 17,200 genes was used in a highthroughput manner to identify essential genes in 12 different cancer cell lines (Luo et
al., 2008). Another study used shRNA pools of different scales ranging from 6,000 to
20,000 shRNAs to investigate fitness genes in 5 cell lines from human mammary
tissue (Silva et al., 2008). Multiple loss of function shRNA screens conducted by
different groups pinpointed sets of core dependencies that are essential in all cell
lines. These core essential genes were found to be enriched in processes related to
the core machineries of the cell such as transcription, translation, proteosome, mRNA
splicing, ribosome, cell cycle regulators and other housekeeping genes (Kittler et al.,
2004; Luo et al., 2008; Schlabach et al., 2008; Silva et al., 2008).
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One important observation from these screens was that how the cells tolerated
the knockdown of the essential genes showed differences between different cell lines.
In one shRNA study that targeted 2924 genes in 4 cell lines, it was observed that the
number of essential genes showed variance between cell lines (ranging from 3% to
23.8 of the genes tested) and that several genes were differentially essential in
specific backgrounds (Schlabach et al., 2008). Therefore, besides identification of
core essential genes, shRNA screens were also used in order to find context
dependent essential genes in different backgrounds. This idea is very significant in
the context of cancer since context dependent essential genes in cancer cells
represent genomic vulnerabilities that can potentially be targeted with novel
therapeutic agents. Studies showed that a subgroup of colorectal cancer cell lines
showed dependency on a specific KRAS mutation for growth and survival (Shirasawa
et al., 1993). After these studies, the term “oncogene addiction” was developed, which
describes the dependency of cancer cells on particular oncogenes for continuous
growth and proliferation (Weinstein and Joe, 2008). Several RNAi screens were then
performed on small arrays of cancer cells to search for these oncogenic essentials
(Moffat et al., 2006; Schlabach et al., 2008; Silva et al., 2008). Some examples of
these context specific essential genes are the IRF4 transcription factor in multiple
myeloma cell lines (Shaffer et al., 2008), Brd4 in a mouse model of acute myeloid
leukemia (AML) (Zuber et al., 2011) and BCR-ABL dependency in K562 chronic
myelogenous leukemia (CML) cell line (Luo et al., 2008).
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Based on the promising results from these studies towards identification of
therapeutically targetable cancer-specific vulnerabilities, Project Achilles was
launched to characterize essential genes using an shRNA library with 11,000 genes
across 216 human cancer cell lines (Cowley et al., 2014). Similarly, another relatively
large scale study in 72 cell lines from pancreatic, ovarian and breast cancer tissues
(Marcotte et al., 2012) revealed concordant results with a similar study (Cheung et al.,
2011), indicating confidence in the methodology. With development of improved
computational approaches in the analysis of genome-wide loss of function screens,
an initial set of 291 core essential genes were identified across 48 cell lines (Hart et
al., 2014). In 2017, Cancer Dependency Map effort was initiated at the Broad Institute
to predict and map cancer dependencies using data from genome-scale shRNA
screens from 501 cell lines (Tsherniak et al., 2017). This study identified 769
differentially essential genes across the cell lines screened in the study. In a similar
large-scale effort to identify therapeutic targets, Project DRIVE (Deep RNAi
Interrogation of Viability Effects in cancer) assessed 7,837 genes for dependencies
using a lentiviral shRNA library of a median of 20 shRNAs per gene across 398 cancer
cell lines (McDonald et al., 2017). Project DRIVE also identified tissue specific
oncogenes, synthetic lethal interactions, lineage-specific transcriptional factors as well
as genetic interaction networks.

1.2.4 Disadvantages of the RNAi technology
The RNAi technology provided a lot of valuable insights for elucidating gene
function and characterizing essential genes. However, the popularity of the method
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diminished as several significant disadvantages were identified. Even though
significant efforts have been made to optimize shRNA design and computational
methods, RNAi technology exhibited important limitations. One such limitation is the
incomplete loss of function due to RNAi, resulting in partial knockdown of the target
gene and leading to false negative results during the analysis of the screens (Moore
et al., 2010; Sigoillot and King, 2011). Another problem is the decreased sensitivity of
the RNAi technology especially for genes with low expression levels, again leading to
a significant false negative rate (Hart et al., 2014; Hong et al., 2014; Hu, 2004).
Besides the false negatives arising due to technological limitations, false positives due
to off-target effects are another major drawback of the RNAi system. Off-target effects
refer to the observed phenotypes in shRNA screens, which arise from unintended
interactions between the reagents and their accidental targets. Majority of these offtarget effects are dependent on nucleotide sequence of the shRNA and are due to the
high tolerance for mismatches between the guide and the target mRNA (Birmingham
et al., 2006; Boutros and Ahringer, 2008; Echeverri et al., 2006; Jackson et al., 2003).
This problem is especially important during the analysis and interpretation of genomescale screens to identify essential genes as the unintended gene targets of the shRNA
guides can be falsely labelled as an essential gene (Echeverri et al., 2006; Kaelin,
2012). To overcome this limitation, the experiments can be designed so that every
gene is targeted by multiple shRNAs to serve as a control with the expectation that
they will result in the same phenotype (Echeverri et al., 2006). Because of these
reasons, RNAi screens have to be designed and analyzed carefully, confirming results
with orthogonal approaches.
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1.3 Identification of essential genes with CRISPR-Cas9
technology
Compared to gene knockdown achievable with the RNAi system, gene
knockout is a more reliable method to study gene function. With the advancement of
genome editing technologies, Clustered Regularly Interspaced Short Palindromic
Repeats (CRISPR) system offers a useful tool to achieve gene knockdown and to offer
new insights during functional genomics studies.

1.3.1 CRISPR-Cas9 system in bacteria
Clustered regularly interspaced short palindromic repeat sequences were first
recognized in E.coli before the term CRISPR was initially put together (Ishino et al.,
1987). With advances in genomic sequencing, it was realized that these repeated
elements, which appear in clusters, were present in members of distant phylogenic
groups. However, unlike the regular tandem repeats in the genome, these sequences
were shown to be separated by unique intervening sequences of uniform length called
spacers (Mojica et al., 2000). As the genomes of several organisms were sequenced
and compared with one another with computational methods, it was shown that these
repeat and spacer elements were conserved within a species. More importantly, these
regions were close to CRISPR associated genes (Cas) that showed homology in
different species but their function was not clear (Jansen et al., 2002). Later it was
realized that these elements were homologous to the genomic sequences of the
phages (Mojica et al., 2005) and that CRISPR and the Cas proteins played a role in a
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natural defense mechanism in bacteria as a way to evade viruses and bacteriophages
(Barrangou et al., 2007). Immunity through CRISPR-Cas system in bacteria works by
first integrating fragments of DNA, approximately 30 base pairs in length, from
invading viruses into their bacterial genome at the leading edge of the CRISPR locus
as spacers. In order for this acquisition process to occur, the host needs to select
spacer precursors (proto-spacers) by recognizing protospacer adjacent motif (PAM)
in the viral DNA, the sequence of which shows variability depending on different
CRISPR systems (Makarova et al., 2011). During the next stage of expression, a long
primary transcript (pre-cRNA) is transcribed with multiple spacers and then processed
into short CRISPR RNAs (crRNAs) (Makarova et al., 2011; Wiedenheft et al., 2012).
Each of these mature crRNAs contain a repeat and a spacer and forms a cascade
with a Cas protein to form a crRNA-effector complex (Makarova et al., 2011). In the
interference phase, the viral DNA/RNA is cleaved as the crRNA guides the crRNAeffector complex to the complementary target sequences that match the spacer
sequences, preventing the replication of invading viral genetic material (Makarova et
al., 2011; Wiedenheft et al., 2012).

Researchers who investigated Streptococcus pyogenes CRISPR

system

found out that the crRNA interacted with a constant tracrRNA to form an RNA duplex
(Deltcheva et al., 2011). Moreover this crRNA-tracrRNA complex in S.pyogenes was
shown to bound to the Cas9 protein which is the endonuclease that cuts target DNA
in type II CRISPR systems (Jinek et al., 2012). Strikingly, the authors also showed
that this system can be used to cleave DNA in vitro with the engineering of a chimeric
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20 nucleotide long single guide RNA (gRNA or sgRNA) which carries sequence
complementarity to the target DNA (Jinek et al., 2012). Finally, later studies focused
on the expression of the Cas9 and gRNA in eukaryotic cells to achieve programmable
genome editing (Cong et al., 2013).

1.3.2 Adaptation of CRISPR to mammalian cells
Application of the bacterial CRISPR-Cas9 system for use in mammalian cells
revolutionized the field of functional genomics, providing fast, systematic and highthroughput genome editing. Previous technologies such as homology directed repair
(HDR) were inefficient with precise modification occurring in only 1 in 106- 109 cells
(Capecchi, 1989). Soon it was discovered that DNA double strand breaks (DSBs)
were repaired by either HDR or the error prone non-homologous end joining (NHEJ),
which results in short insertions and deletions (Bibikova et al., 2002). To facilitate
DSB formation as more effective gene editing, zinc finger nucleases (ZFNs) were
developed using series of zinc finger domains from transcription factors in eukaryotes
(Urnov et al., 2010). Similar to ZFNs, transcription-activator like effector nucleases
(TALENs) consist of fusions of a cleavage domain with DNA binding domains from
TALE proteins. They contain TALE arrays with 10-30 repeats which control DNA
binding. Like ZNFs, TALENs can create targeted double stranded breaks to activate
DNA damage response and enable genome editing (Gaj et al., 2013; Gupta and
Musunuru, 2014). Although these nucleases can be programmed to achieve precise
genome editing in mammalian cells, both technologies are too laborious and they
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require significant optimization steps, making them unsuitable for large scale and
routine applications.

Despite the difficulties of the ZFNs and TALENs, CRISPR-Cas9 technology
offers a more simplistic and highly efficient genome editing capabilities in multiple
organisms. The genome editing function of CRISPR-Cas9 system from bacteria was
recapitulated in mammalian cells by expressing sgRNAs with optimized Cas9 with the
addition of nuclear localization signals. 20 base pair sgRNAs are designed to target a
specific site in the genome that is immediately 5’ of the PAM sequence, which is
“NGG”, for it to be recognized by S. pyogenes Cas9. After being guided by the sgRNA
to the target sequence, Cas9 cleaves the DNA, inducing a double strand break which
is repaired by the NHEJ or the HDR pathway if a donor DNA template is provided
(Cong et al., 2013; Jinek et al., 2013; Mali et al., 2013). The simplicity of the method
also enabled the creation of large sgRNA libraries and multiplexing by expressing
multiple sgRNAs on a single vector to study genetic interactions (Cong et al., 2013;
Mali et al., 2013).

1.3.3 Genetic screens using CRISPR-Cas9 technology
Adaptation of the bacterial CRISPR-Cas9 system to mammalian cells enabled
genome-scale approaches to define human essential genes. Prior to this technology,
RNAi was the best performing method to perform loss of function screens to study
gene essentiality. However, as discussed previously, due to incomplete loss of
function, decreased sensitivity for genes with low expression levels and confounding
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off-target effects, RNAi lost its popularity as the potential therapeutic targets identified
through these screens could not be validated in other studies. Compared to the RNAi
technology, CRISPR-Cas9 system induces a complete loss of function in the target
genes by creating a double strand break in the DNA, which is repaired by NHEJ repair
because a homology template is not provided. This error-prone repair mechanism
creates indels which lead to frameshift mutations or a premature stop codon that
results in a truncating mutation and to loss of function. Using this efficient genome
editing tool, several groups designed pooled genome-wide CRISPR-Cas9 knockout
libraries to perform loss of function screens (Koike-Yusa et al., 2014; Shalem et al.,
2014; Wang et al., 2014). In these screens, Cas9 is delivered into cells either on the
same lentiviral vector as the chimeric sgRNA, which is expressed through a U6 RNA
polymerase III promoter, in a one-component system (Shalem et al., 2014) or on a
separate vector (Koike-Yusa et al., 2014; Wang et al., 2014) in a dual component
system.

In the genome-scale CRISPR-Cas9 knockout (GECKO) library study, ~18,000
genes were targeted with 64,751 sgRNAs to identify essential genes in a melanoma
cell line and the authors observed that guides targeting expected essential genes were
significantly depleted (Shalem et al., 2014). The same study also performed a positive
selection screen to investigate genes essential for developing resistance to
vemurafenib and identified NF1 and MED12 genes as hits. Another study screened
two leukemia cell lines with a library targeting ~7,000 genes with 10 sgRNAs per gene
and observed that genes that are involved in fundamental biological processes of the
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cell showed the greatest depletion (Wang et al., 2014). Moreover, this study
investigated features that determine sgRNA efficiencies and built an algorithm to
predict strong sgRNAs. The other genome-scale library used ~88,000 guides to target
~19,000 mouse genes and identified several genes that regulate mechanisms of
resistance to Clostridium alpha-toxin or 6-thioguanine in mouse embryonic stem cells
(Koike-Yusa et al., 2014).

These first-generation proof of concept genome-scale CRISPR-Cas9 knockout
screens provided significant insights that were essential for the development of
efficient next generation libraries. These libraries were used in negative selection
screens to expand the sets of essential genes in human cancer cells (Hart et al., 2015;
Wang et al., 2015). The Hart et al. study used the high complexity Toronto Knockout
version 1 (TKOv1) library targeting 17,661 protein coding genes to find essential
genes in a diverse set of cancer cell lines arising from different lineages (Hart et al.,
2015). With negative selection screens using TKOv1 library in 5 cell lines, the authors
identified ~2000 high confidence fitness genes in each cell line and strikingly this
finding revealed that CRISPR technology can identify 4-5 times as many hits as RNAi
screens with the same false discovery rate (FDR) in the same HCT116 cell line (Hart
et al., 2015). An independent study by Wang et al used an optimized sgRNA library in
chronic myelogenous leukemia and lymphoma cell lines and also identified ~2000
essential genes in a cell line (Wang et al., 2015). Another study in 5 acute myeloid
leukemia (AML) cell lines used a ~90,000 sgRNA library to target ~18,000 genes and
identified approximately 2,000 essential genes at 20% FDR (Tzelepis et al., 2016).
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All of these aforementioned studies demonstrated that CRISPR-Cas9
technology offers a superior sensitivity in detecting essential genes, accomplishing
genetic knockout by directly targeting DNA compared to RNAi which targets mRNA
transcripts to trigger reduced gene function. However, CRISPR technology also
showed some important limitations. The first limitation was due to the fact that the
sgRNAs for CRISPR-Cas9 libraries were designed to target the 5’ coding exon of the
target gene. This sometimes results in frameshift or in-frame mutations which can
retain their functions and thus can hinder the knockout phenotype (Shi et al., 2015).
Alternatively, sometimes exons other than those located at the most N-terminal region
can contain an alternative transcription initiation site which might be sufficient for gene
expression, creating a lack of dropout phenotype (Munoz et al., 2016). Fortunately this
limitation can be overcome by targeting exons containing conserved functional protein
domains which creates a higher ratio of

null mutations and increased negative

selection (Munoz et al., 2016; Shi et al., 2015). A similar genome-wide CRISPR-Cas9
loss of function also showed that targeting conserved protein coding regions of a gene
with sgRNAs causes more significant depletion than targeting the same gene in a
less conserved region (Bertomeu et al., 2018).

Another important confounding factor during the analysis and interpretation of
genome-wide CRISPR-Cas9 knockout screens are the false positive knockout
phenotypes that are due to gene-independent effects in copy number amplified
regions. This phenomenon is observed because multiple double stranded breaks are
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induced when sgRNAs target amplified loci, triggering DNA damage response,
resulting in increased phosphorylation of H2AX, subsequent cell cycle arrest and
apoptosis (Aguirre et al., 2016; Munoz et al., 2016; Wang et al., 2015). It is important
to correct for these gene independent effects especially during identification of
essential genes since the genes that reside in copy number amplified regions will
exhibit strong loss of function phenotypes, being falsely labeled as essential genes.
To correct for these potential false positives from genome-scale CRISPR-Cas9
knockout screens, different computational algorithms such as CERES (Meyers et al.,
2017) and CRISPRcleanR (Iorio et al., 2018) have been developed and are widely
used.

1.3.4 Large scale efforts of CRISPR-Cas9 screening to identify
genomic vulnerabilities in cancer cells
Recently, there have been massive efforts by the Broad Institute of MIT and
Harvard and the Wellcome Sanger Institute under the collective Cancer Dependency
Map project (DepMap Consortium), which aims to identify cancer specific weaknesses
through genetic perturbations across hundreds of cancer cell lines from multiple
cancer types (Behan et al., 2019; Meyers et al., 2017; Tsherniak et al., 2017). These
datasets include experimental data from CRISPR-Cas9 genome-scale loss of function
screens as well as mutation, gene expression and copy number data from hundreds
of human cancer cell lines. New data from additional cell lines are released quarterly
in the DepMap portal under Project Achilles, which currently has data from 808 cell
lines screened with the Avana library in the 2020Q4 release (Broad DepMap, 2020a).
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Similarly, the Sanger Institute has released data under the Project Score which
comprises 324 whole-genome CRISPR-Cas9 screens to identify cancer specific
dependencies (Behan et al., 2019). For the first time, these publicly available datasets
enabled researchers to conduct systematic analyses from hundreds of cell lines to
identify genomic dependencies that can be targeted therapeutically. After the release
of these massive datasets, computational tools were also developed specifically to
correct for the false positive essential genes that arise due to gene-independent
effects in copy number amplified regions (Iorio et al., 2018; Meyers et al., 2017). An
extensive analysis of the Sanger dataset with more than 300 cell lines revealed
dependence on known oncogenes, such as cellular reliance on BRAF in BRAF
mutated cells. One novel finding from this study was the Werner syndrome ATPdependent helicase (WRN) as a synthetic lethal therapeutic target for tumors that
show microsatellite instability (MSI).

1.3.5 Genetic interactions and synthetic lethality
Genome-scale CRISPR-Cas9 knockout screens focus on evaluating the
functional impact of individual gene perturbations in order to identify cellular
dependencies. As described in the previous sections, these studies have identified
about 10% of the genes in the human genome as essential, indicating the significance
of functional buffering. Hence, it is important to highlight the significance of genetic
interactions, which explains the presence of context-dependent essential genes, the
loss of which creates a fitness defect in only a specific genetic background.
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A genetic interaction between two genes is defined as an unexpected
phenotype that arises from mutations of both genes (Costanzo et al., 2010; Mani et
al., 2008; Tong, 2004). If the mutations in two genes results in an increased
proliferation phenotype, this gene pair is considered to have a positive genetic
interaction. Conversely, if the mutations in two genes results in reduced fitness
compared to the expected phenotype, these two genes show a negative genetic
interaction. The severity of the negative genetic interactions can range from being mild
as in synthetic sick interactions to the most severe form which is synthetic lethality.

The concept of synthetic lethality is particularly significant in the context of
cancer since exploiting cancer specific vulnerabilities to target cancer cells while
leaving the normal tissue unharmed is the dream of cancer therapy. Synthetic lethality
can be seen as a type of context-dependent gene essentiality where the inhibition of
a particular gene kills only the cancer cells which have a loss of function of its
synthetic lethal pair, without effecting normal cells that do not have the same loss of
function phenotype. It can also be considered as an essential functional interaction
between two nonessential genes. Therefore, synthetic lethal interactions are
considered as promising therapeutic targets in personalized medicine due to
conceivably reduced side effects as well as the potential to indirectly target previously
non-targetable genes. Since many tumor suppressors and oncogenes cannot be
targeted easily by pharmacological agents, there is an urgent need to identify genes
that become emergently essential when they interact with tumor suppressors or
oncogenes.
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Despite its enormous promise, not many clinically relevant synthetic lethal
interactions have been successfully translated for use in the clinics. The most wellknown example is the PARP inhibitor olaparib which is the first clinically approved
drug to exploit synthetic lethality between the BRCA1/2 and PARP genes (Lord and
Ashworth, 2017, 2008). Since cancer cells that have homozygous BRCA1/2 loss of
function mutations become dependent on PARP activity, the treatment of these cells
with a PARP inhibitor results in cellular death (Bryant et al., 2005). This phenomenon
is observed because a complete loss of function of BRCA1/2 renders the cell without
a functioning homologous recombination DNA repair mechanism, which is responsible
for an error free double strand break repair. PARP encodes for a nuclear protein that
plays a role in base excision repair, which is a type of DNA single strand break repair.
PARP inhibitors block the base excision repair mechanism in the BRCA1/2 mutated
homologous recombination deficient cells. This results in a nonfunctioning DNA repair
mechanism in the cell leading to accumulation of mutations, genomic instability and
cell death (Lord and Ashworth, 2017). PARP inhibitors have been used for BRCA1/2
mutated breast ovarian cancer and they have shown to be most effective in platinum
sensitive patients (Konecny and Kristeleit, 2016). Although BRCA deficiency occurs
in only a fraction of cancer patients, the idea of synthetic lethality has inspired
researchers to build genetic interaction networks to discover novel synthetic lethal
interactions that can be exploited therapeutically.

1.4 Overview of dissertation research
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In cancer therapy, killing cancer cells selectively without harming surrounding
healthy tissue remains a major challenge. The toxicity of conventional treatment
methods to the normal cells stresses the need for new strategies that can identify and
address the weaknesses specific to cancer cells. Genetic knockout screens identify
essential genes and can be performed on a genome scale in mammalian cells using
CRISPR-Cas9 technology. While it is widely accepted in the field that CRISPR
screening is both more specific and more sensitive than previously established
methods, the limitations of this technology have not been systematically investigated.
Moreover, current methods to precisely define essential genes depend on arbitrarily
defined thresholds, which results in an inaccurate definition of core, context and nonessential genes across hundreds of different backgrounds.

The overall objective of this dissertation is to use pooled genome-wide
CRISPR-Cas9 loss of function screens to advance our understanding of human gene
essentiality and identify context-dependent essential genes and vulnerabilities in
different cancer types. Chapter 2 will focus on the systematic analysis of CRISPR
screens from hundreds of cell lines to demonstrate the biases in these screens. The
analyses will include development of a computational approach that models the actual
expected number of essential genes in an average pooled genome-wide CRISPRCas9 loss of function screen, estimation of the FDR and false negative rate (FNR) in
a “typical” CRISPR screen using data from the Broad and Sanger screens. These
analyses will establish a ground truth for a typical CRISPR screen. Moreover, another
modeling approach that defines high-confidence core and context essential genes in
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these screens will be discussed. Chapter 3 will focus on the false negative (FN)
problem in these screens and will address this challenge using another computational
method. Therefore, these two chapters will demonstrate a detailed analysis of these
genome-wide CRISPR screens, focusing on what we can learn from these screens.
On the other hand, Chapter 4 will focus on the blind-spots in monogenic knockout
screens, highlighting the significance and implications of the type of information that
we are missing from the previous analyses. Collectively, these chapters will improve
our understanding of human gene essentiality, taking us one step further from the
foundational concepts described in the previous sections. The analyses will reveal
significant biases and blind-spots in the analysis of CRISPR-based functional
genomics approaches, and offer new opportunities for the discovery of novel
candidate drug targets.
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Chapter 2: Identification

of

high-confidence

essential genes and the biases in CRISPR-Cas9
knockout screens
The majority of analyses found in this chapter are adapted from the following
preprint manuscript using an updated version of the Avana data release (2020Q2):
Dede, M., Kim, E., & Hart, T. (2020). Biases and Blind-Spots in Genome-Wide
CRISPR Knockout Screens. BioRxiv.
The copyright holder for this preprint is the author/funder, who has granted
bioRxiv a license to display the preprint in perpetuity. It is made available under a CCBY 4.0 International license.

2.1 Abstract
With the adaptation of bacterial CRISPR-Cas9 system to mammalian cells and
developments in genome-wide pooled CRISPR-Cas9 knockout screening, studies
have shown that CRISPR technology enables greater sensitivity and specificity
compared to previous gold-standard technologies in detecting essential genes.
Although these developments have been instrumental for the identification of
targetable cancer specific vulnerabilities, the assumption that CRISPR screens are
saturating has been largely untested. In this chapter, I describe my work on an
integrated analysis of genome-wide screen data in cancer cell lines generated by the
Cancer Dependency Map from the Broad Institute and Project Score by the Sanger
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Institute, to estimate the expected number of essential genes in an average genomewide CRISPR-Cas9 screen, establish a false positive (FP) and a false negative rate
(FNR). I will demonstrate different biases that we observe and will also define a set of
high-confidence common and context essential genes across these datasets to define
tissue specific vulnerabilities.

2.2 Introduction
The search for essential genes - genes whose loss of function results in a
severe fitness defect - has been of outstanding interest to the scientific community.
Prior to advanced genomic technologies, the assumption was that the majority of
genes were essential for life (Horowitz and Leupold, 1951). This idea was dismissed
by several studies that utilized saturating random mutagenesis to show that in C.
elegans and S. cerevisiae, 12-15% of the genome was estimated to be essential
(Brenner, 1974; Goebl and Petes, 1986). These studies were limited by the methods
at the time and the lack of the availability of complete genome sequences.

After improvements in shotgun sequencing, initial studies to define essential
genes in bacteria were driven by the desire to identify antimicrobial targets with the
first minimal genome screen performed in Mycoplasma genitalium (Hutchison et al.,
1999).Later studies revealed the essential genes in other bacteria including M.
tuberculosis, P. aeruginosa and H. influenza (Akerley et al., 2002; Jacobs et al., 2003;
Sassetti et al., 2001).
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With the advances in genome technologies that enabled sequencing of
eukaryotic organisms, systematic gene knockout studies were performed in S.
cerevisiae, identifying essential genes by deletion of open reading frames in the yeast
genome This method identified that 17% of yeast genes were essential for growth in
rich medium (Winzeler et al., 1999). However, a later study showed that a binary
classification of genes into essential and non-essential was misleading due to the
context dependent nature of gene essentiality and that 97% of yeast genes showed
some growth phenotype under different environmental conditions (Hillenmeyer et al.,
2008).

Developments in RNA interference (RNAi) technology provided valuable
insight into detection of fitness genes. Generation of genome scale RNAi libraries to
conduct genome-wide RNAi screens facilitated the study of essential genes in multiple
organisms (Dietzl et al., 2007; Kamath et al., 2003; Meister and Tuschl, 2004; Moffat
and Sabatini, 2006). In these RNAi screens, 30% of the genome was shown to be
essential in D.melanogaster cell lines, (Dietzl et al., 2007), compared to only 8.5% of
the C.elegans genome in whole worms (Kamath et al., 2003).

Identifying essential genes in human cancer cells is of special interest in
oncology since the cancer-specific essential genes represent genomic vulnerabilities
that can potentially be targeted with novel therapeutic agents. An initial study showed
that some colorectal cell lines were dependent on a specific KRAS mutation for growth
and survival (Shirasawa et al., 1993). Later this idea was explored under the term
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“oncogene addiction” that describes the dependency of cancer cells on specific
oncogenes for sustained growth and proliferation (Weinstein and Joe, 2008). To
identify these oncogenes, RNAi screens were performed on small arrays of cancer
cells to search for essential genes (Moffat et al., 2006; Schlabach et al., 2008; Silva
et al., 2008). Subsequent larger-scale efforts such as the Project Achilles of the Broad
Institute focused on context specific gene essentiality across 216 human cancer cell
lines screened with an shRNA library (Cowley et al., 2014).

Similarly, another

relatively big scale study in 72 cell lines (Marcotte et al., 2012) produced consistent
results with the previous studies, indicating confidence in the methodology. Even
though significant efforts have been made to optimize reagent design and analytical
methods, RNAi technology was shown to have significant limitations such as
incomplete loss of function due to RNAi, decreased sensitivity for genes with low
expression levels (false negatives) and confounding off-target effects (false positives)
(Boutros and Ahringer, 2008; Echeverri et al., 2006; Hart et al., 2014).

More recently, adaptation of the bacterial CRISPR-Cas9 system to mammalian
cells enabled genome-scale approaches to define human essential genes. Studies
using this technology revealed that mammalian cells have more essential genes than
RNAi screens were able to detect and that, at the same false discovery rate, CRISPR
screens generated 3-4 times more essential genes (Hart et al., 2014). Moreover,
multiple groups revealed lists of ~2000 highly concordant human essential genes, and
comparison of CRISPR technology to orthogonal techniques such as random insertion
of gene traps also showed consistent results (Blomen et al., 2015a; Hart et al., 2015;
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Wang et al., 2015). These findings were initially thought to indicate that the CRISPRCas9 screens are saturating and that a well-designed screen can detect a cell's full
complement of essential genes. However, it is still poorly understood how the possible
systematic biases in CRISPR screens affect our understanding of human gene
essentiality. In the absence of a ground truth, the actual true positive, false positive
and false negative rates are in an average genome-wide CRISPR-Cas9 knockout
screen are still unknown. In this chapter, we will conduct a systematic analysis of
genome-wide CRISPR-Cas9 knockout screens to model how many essential genes
we expect to find in an average CRISPR screen, estimate the false discovery and
false negative rates and reveal the biases we observe in our analyses.

2.3 Results
2.3.1 Overview of the Avana data
In order to perform a systematic analysis of the screens, we obtained the raw
read counts of pooled genome-wide CRISPR-Cas9 loss of function screens performed
in 769 genetically heterogeneous cell lines from the 2020Q2 release of the publicly
available Avana data (Broad DepMap, 2020b; Meyers et al., 2017). We processed the
data by applying our computational pipeline as described in detail in the methods
section in 2.5. Briefly, we utilized the CRISPRcleanR algorithm (Iorio et al., 2018) to
correct for gene-independent copy number artifacts and calculated the log2FC for
each gene in every screen. Next, we evaluated gene essentiality by assigning an
essentiality score, Bayes Factor (BF) to each gene in every screen using a recently
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updated version of our BAGEL algorithm (Kim and Hart, 2021). After applying quality
control metrics by evaluating the precision recall curves, (Figure 2.1A) and calculating
F-measures, we constructed a final dataset of 659 cell lines which satisfied the Fmeasure criteria of 0.8 and above (Figure 2.1B).

Figure 2.1. Avana data quality control metrics. A) Precision-recall curves for a high quality
versus low quality screen. The red dots indicate where the Bayes Factor equals 5. B) The
histogram of F-measures show that the majority of Avana screens are high-performing, with
86% of the screens displaying F-measures greater than or equal to 0.80 as indicated by the
red dashed line.

These 659 cell lines are derived from 25 different tissue types, with varying
representation (Figure 2.2).
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Figure 2.2. Avana cell lines constitute 25 tissue types in 2020Q2 release. Red bars indicate
tissues that are represented by more than or equal to 16 cell lines and blue bars represent
tissue types with less than 16 cell lines.

2.3.2 Synthetic genome modeling of essential genes in 659 cell
lines in the Avana data
To estimate the total number of essential genes in a cell, we employed a
method based on the cumulative essentiality observations across all screens in the
Avana data. Our approach is based on the expectation that, for a sufficient number of
identical screens without any false positives, a plot of the cumulative number of
essential genes would flatten to a slope of zero when all of the essential genes in the
population are identified. In contrast, in a population of screens with either cellular
heterogeneity or some degree of false discovery rate (most likely both), the slope of
the cumulative essential genes plot would remain positive, reflecting the continuous
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accumulation of false positives as well as cell line specific essential genes in otherwise
saturated screens. This principle was previously demonstrated to estimate the total
population of essential genes detectable with RNAi technology (Hart et al., 2014).

We applied this logic to the Avana dataset and plotted the cumulative essential
genes across sets of 20 cell lines that are randomly selected without replacement from
all Avana screens (Figure 2.3). The sampling process was repeated 100 times to
prevent bias in the selection of screens.

Figure 2.3. Avana screens have a cumulative essentials plot with a positive slope. The blue
circles indicate the number of cumulative essential genes in each screen and the green
triangles indicate the number of newly discovered essential gene hits in each consecutive
screen. The error bars indicate the standard deviation of the number of cumulative essential
genes and the newly discovered essentials in 100 iterations. The black line indicates the
saturation point at 8 screens.
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To define gene essentiality, a strict threshold of BF>10 was used for every
gene in each screen since this threshold represents a posterior probability of gene
essentiality of ~99% (Figure 2.4).

Figure 2.4. The relationship between the posterior probability of essentiality and Bayes
Factors. BF of 10 (black dashed line) represents a posterior probability of essentiality of 99%
indicated by the red dashed line.

Using this BF 10 threshold yielded a cumulative essentials curve that
converged to a positive slope, which was consistent with previous observations in the
shRNA screens (Figure 2.3). This plot represents significant trends in the data: first,
there exists a fixed population of essential genes across all screens. The number of
cumulative essentials increase rapidly at first and then the curve continues with a
positive slope as more screens are added. Second, the screening methodology
cannot confidently capture all the essential genes in a single experiment. An average
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screen renders between 1250-1300 essential gene hits but the saturation point
indicated by the black line in Figure 2.3 indicates ~2500 hits. Therefore, it is obvious
that all essential genes cannot be captured in a single experiment and each screen
carries some unknown false negative rate (FNR). Multiple screens are needed before
all essential genes in the population can be identified. Third, after the saturation point
is reached, additional screens continue to accumulate a combination of false positives
as well as context-specific essential genes that were either not detectable or not
present in the prior set of screens, and that the rate at which these genes are observed
offers some estimate of the false discovery rate of each screen.

To model these factors, we carried out repeated screens in silico and compared
synthetic cumulative essential curves to those derived from the data. Starting with a
genome of N=18,111 genes – the number of genes tested in the Avana library – we
arbitrarily defined n essential genes, leaving N-n nonessential. We further defined an
arbitrary screen false discovery rate between 1-15%. Then we repeatedly sampled
this genome with a screen that randomly drew 1,287 hits – the mean number of hits
at BF>10 across all Avana screens -- from the essential and nonessential populations
based on the defined FDR (e.g. at 10% FDR, 129 nonessentials and 1,158 essentials
were randomly selected; see Figure 2.5A). Finally, we determined the cumulative hits
across eight iterations, estimating that eight samples was a good estimate of screen
saturation in the data (sFigure 2.3) and judging that it was more important to fit the
model to our observations in this region than in the saturated region. We calculated
the root-mean-squared deviation from the mean cumulative essentials curve
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determined from the Avana data and plotted RMSD vs. the two parameters of the
model observing that the best fit occurred with n=1,600 essential genes and
FDR=9.5% (Figure 2.5B,C). Notably, a region of good fits, with RMSD < 2xRMSDmin,
occurs between n=1,500-1,800 essential genes and a corresponding decrease in perscreen FDR from 9.5% to ~6.5% (Figure 2.5D).

A

B

C

D
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Figure 2.5. Synthetic genome modeling estimates 1600 essential genes in an average
screen and 9.5% FDR. A) Diagram overview of the synthetic genome modeling of essential
genes. From a synthetic genome of 18,111 genes, 1287 hits were randomly sampled from
the essential (n) and non-essential gene (NEG) populations based on the defined false
discovery rate (FDR) in the simulation. The resulting cumulative essential hits across 8
iterations were plotted and compared to the mean cumulative essentials curve from the
Avana data. B) The synthetic genome modeling reveals that the best fitting model with
n=1600 genes and 9.5% FDR indicated by the white box. C) Plot showing the model with
the best fit (in blue) to the Avana data 2020Q2 release (red). D) Box-plot showing the
distribution of the RMSD values for each simulation. The red dashed line indicates twice the
minimum RMSD with models below this line representing region of good fits.

Considering the range of different tissue types that the screened cell lines are
derived from, it is clear that some of the context-specific essential genes will be
included in the false positives in our synthetic genome approach. In order to minimize
the effect of these tissue-specific essential genes, we repeated the analysis using cell
lines from only one tissue type, filtering for 18 tissues that are represented by at least
16 high performing screens (Figure 2.2). Each tissue type yielded similar cumulative
essential curve (Figure S2.1) as shown here for the colorectal cancer cell lines in the
Avana data (Figure 2.6). We repeated this modeling approach in each tissue type and
obtained remarkably similar results (Figure S2.2).
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Figure 2.6. Synthetic genome model identifies the number of essential genes in each tissue
type. A) Synthetic genome model estimates 1600 essential genes and 10% FDR among
colorectal cancer cell lines in the Avana data (white rectangle). The red circle represents
the region of good-fit models with less than twice the minimum RMSE values. B) Plot
showing the model with the best fit (in blue) to the Avana colorectal cancer cell line data
(red).

Next, we compared the best-fit number of essential genes from the synthetic
genome model in each tissue type to the mean number of essential gene hits observed
in that same tissue type and calculated an average false negative rate across each
tissue. Across all tissue types we examined, we determined the mean FNR to be
~20% in each screen.
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Figure 2.7. False negative rates in different tissue types in the Avana data. Average screen
FNR was determined by comparing the number of essential genes from the best fit model in
each tissue type to the mean number of observed essentials in each tissue type. The red
dashed line indicates a mean FNR of 21.2% across all tissue types tested.

2.3.3 Saturation modeling to differentiate essential genes and false
positives
While our synthetic genome approach described in the previous section gave
us an estimate of the expected total number of essential genes and the FDR in an
average screen, it does it does not provide any way to differentiate true hits from false
positives. To address this issue, we utilized an alternative view of the saturating
behavior of CRISPR screens, similar to the methodology described for shRNA
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screens (Hart et al., 2014). Based on our judgment that screening in virtually all
lineages achieved saturation after roughly eight cell lines had been effectively
screened, we again selected the lineages with at least twice this number of cell lines
indicated in Figure 2.2. From each of these tissue types, we randomly selected eight
screens (“initial screens”) without replacement, identified the cumulative number of
essential genes (defined by BF>10) and determined the number of cell lines in which
each gene was classified as essential. We then randomly selected an additional eight
screens (“subsequent screens”), again without replacement, and determined the
number of cell lines in which each gene was classified as new hits – that is, BF>10
but not a hit in any of the initial eight screens (Figure 2.8A). We assumed that all of
these new hits were false positives, and that the histogram of observations of these
false positives estimates the frequency of false positives in the initial screens. It is
almost certainly not the case that all of these are actually false positives, given the
known presence of tumor subtypes within each tissue/lineage, the high likelihood of
subtype-specific essential genes, and the probability that any given subtype escaped
being selected in the initial eight screens. However, this assumption is useful for
modeling purposes, as it provides an estimate of the upper bound of the false
discovery rate using this saturation modeling approach. We repeated this process 100
times and plot the resulting histogram (Figure 2.8B, Figure S2.3).
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Figure 2.8. Saturation modeling approach to identify high confidence essential genes. A) The
number of cumulative essential genes and the newly discovered hits in each consecutive
screen among colorectal cancer cell lines in the Avana data. B) Histogram showing the
distribution of the number of essential genes and the number of cell lines in which each gene
was classified as essential in colorectal cancer cell lines. Blue bars represent the distribution
of true positives (TPs) and the orange bars represent the frequency of false positives (FPs).

The histogram in Figure 2.8B indicates that the putative false positives (orange
bars) show the expected distribution that most are detected in only a single screen.
We used the distribution of the true and false positives to estimate both bin-wise and
cumulative false discovery rates (Table S1. Bin-wise FDRs for each tissue type in the
Avana data using saturation modeling approach.) by comparing the ratio of putative false

positives to the total number of hits in each bin. We observed that the bin-wise FDR
falls to less than 3% for genes that are observed in 3 or more out of 8 screens.
Therefore, we determined that genes observed in 3 or more of 8 randomly selected
screens represent the high-confidence set of essential genes in a given tissue type
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and this set includes both genes that are frequently false negatives as well as those
that are subtype-specific within a lineage.

2.3.4 False negatives and subtype specific genes
A closer examination of the U-shaped histogram in Figure 2.8B reveals
significant implications. Genes that are observed as essential in the intermediate
number of screens (3 to 6 out of 8) are either false positives that are repeatedly
observed, false negatives that are repeatedly missed, or cancer subtype-specific
genes that are only essential in some cell lines, violating our modeling assumption
that the cell lines are identical (in reality, some combination of these three possibilities
is more likely). We demonstrate from the hit frequency of the subsequent screens (in
orange) that these genes are very unlikely to be false positives. In this section, we
attempt to differentiate between false negatives and context-essential genes.

First, we examined the mean mRNA expression levels of genes in each bin in
the corresponding cell lines that they were detected as essential. We observed a clear
trend in which more frequently observed essential genes show higher gene
expression (Figure 2.9A). This is in contrast to genes that are observed as hits in only
one out of eight screens, highly enriched for false positives which show markedly
lower expression. Moreover, putative false positives from the subsequent set of 8
screens show a similarly lower average gene expression (Figure 2.9B).
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Figure 2.9. Expression bias exists in CRISPR-Cas9 screens. A) For the true positives in
colorectal cancer cell lines, the mean mRNA expression (log2(TPM)) of the genes in each bin
shows higher expression where more frequently observed essential genes show higher levels
of expression. B) The mean mRNA expression (log2(TPM)) of the genes in each bin for the
false positive gene distribution. C) Violin plot showing the distribution of the essentiality scores
(Bayes Factor, BFs) of the TP genes, in the screens where they were not observed as
essential.
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Next, we questioned the essentiality profiles of genes in the screens where the
gene was not observed as an essential gene. The violin plot in Figure 2.9C measures
whether a gene that is essential (BF>10) in, for example, 5 screens is truly nonessential in the remaining 3 screens with very negative essentiality scores (BF <-10)
or whether it falls in the intermediate range near BF=0. Shows that the more frequently
a gene is classified as essential in the initial screens, the higher its average BF in
screens where it is not essential. This observation is strongly consistent with false
negatives rather than context-dependent essential genes.
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Figure 2.10. Differentiating cancer subtype-specific essential genes from false negatives in
CRISPR-Cas9 screens. Top left panel: Functional enrichment of genes in colorectal cancer
cell lines based on their mean number of hits observations out of 8 screens in 100 iterations.
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Top right panel: mean mRNA expression (log2(TPM)) in colorectal cancer cell lines of the
genes involved in the enriched pathways shown in the left panel. Bottom panel: Hierarchical
clustering of the colorectal cancer cell lines based on the essentiality scores of the genes
involved in pathways shown in left and middle panels.

In order to differentiate between false negatives and cancer subtype-specific
essential genes, we measured functional enrichment of gene annotations as a
function of mean essentiality stringency thresholds. We plotted the P-value of
annotation enrichment for several processes that demonstrate the major trends we
observed in the data. Genes associated with the cytoplasmic ribosome, which should
be universally essential across all cell lines, show peak enrichment at high hit
frequency (hits in n>=7 of 8 screens in 100 random samples from colorectal cancer
cell lines; Figure 2.10 top left panel). Consistent with the expression bias shown in
Figure 2.9A, these genes are very highly expressed in the cell (Figure 2.10 top right
panel). Similarly, genes encoding proteasome subunits which are essential for
proliferation of all cells, show near-maximal enrichment at high frequency of
observation (n>6.5, Figure 2.10 top left panel), and are relatively highly expressed
(Figure 2.10 top right panel). In contrast, genes involved in mRNA export from the
nucleus and RNA degradation—which should also, in principle, be universally
essential—show consistent increase in enrichment as frequency of observation is
relaxed (Figure 2.10 top left panel), and these genes are expressed at intermediate
levels (Figure 2.10 top right panel). Collectively, these trends are consistent with a
significant false negative rate among moderately expressed genes that should
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otherwise exhibit consistent fitness defects across cell lines. Moreover, this trend is
easily differentiated from context-specific modular functions: genes related to
mitochondrial translation and oxidative phosphorylation only show enrichment at low
frequency of observation (Figure 2.10 top left panel), despite their robust gene
expression (Figure 2.10 top right panel). A summary of gene essentiality scores and
trends in the colorectal cancer cell lines displayed here is shown in Figure 2.10 bottom
panel, with context-dependent oxidative phosphorylation genes driving the
hierarchical clustering of cell lines. A more extensive demonstration and discussion of
the false negative genes will be discussed in the following chapter of this dissertation.

2.3.5 High-confidence context-essential genes and a newly defined
set of core essential genes
In section 2.3.3 we had mentioned that genes observed in 3 or more out of 8
screens represent the high-confidence set of essential genes in a given tissue type.
Comparing all tissue types we evaluated in the Avana data, we identified 992 genes
that are essential at that frequency in all 18 tissue types we evaluated (Figure 2.11).
Additionally, we observed that each tissue type carries an additional 300-600 context
specific essential genes (Figure 2.11 inset), which make up the petals of the daisy.
Interestingly, these additional context-essentials are also widely, but not universally,
shared across backgrounds: each lineage has only 3 (central nervous system) to 41
(hematopoietic and lymphoid) genes which are uniquely essential in that lineage. We
found many known gene-tissue relationships in this set of unique context essentials.
For example, the SOX10 transcription factor was found to be essential in only skin
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cells where it plays a major role in the production and function of melanocytes (Harris
et al., 2010; Nonaka et al., 2008). CTNNB1 and TCF7L2 are essential only in
colorectal cancer cell lines, where activation of the Wnt pathway results in
accumulation of B-catenin that interacts with and acts as a coactivator for TCF7L2
that in turn activates downstream genes responsible for colorectal cancer cell survival
as well as resistance to chemo-radiotherapy (Albuquerque and Pebre Pereira, 2018;
Emons et al., 2017; Murphy et al., 2016). ER+ breast cancer cell lines specifically
depend on transcription factors FOXA1 and GATA3, which are overexpressed in ER+
breast carcinomas (Albergaria et al., 2009; Davis et al., 2016). E2F1, which was
uniquely essential in only pancreatic cancer cells, has been previously shown to
regulate both pancreatic B-cell development and cancer growth by increasing the
expression of PDK1 and PDK3 which results in increased aerobic glycolysis and
growth in pancreatic cancers (Denechaud et al., 2017; Kim and Rane, 2011; Wang et
al., 2016).
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Figure 2.11. High confidence essential genes show significant overlap between tissue types.
Top: The new daisy model of gene essentiality. In this model, genes essential in a certain
tissue type is represented by the petals of the daisy indicating their numbers for each tissue.
The petals overlap to varying degrees, but everything shares the common set of essential
genes (N=992). Bottom: Upset plot showing the overlap of high-confidence essential genes
in different tissue types.
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Nevertheless, we demonstrate that genes uniquely essential in a particular
context are very rare, while hundreds of genes are shared across some but not all
tissue types.

2.3.6 Comparing common essentials to previous gold standard
core essential genes
The common essentials defined in this study include genes that are identified
as hits in every tissue type at a frequency of at least 3/8 screens. Therefore, they
should, in principle, define a superset of previously defined gold standard sets of core
essential genes. We compared our set of 992 common essential genes as depicted
as the core of the daisy in Figure 2.11 to the Core Essential Genes v2 (CoreV2) that
we had previously defined as a gold standard training set for our BAGEL algorithm
(Hart et al., 2017), as well as the core essentials defined by the recently published
Sanger dataset performed at the Wellcome Trust Sanger Centre (Behan et al., 2019).
The newly identified common essentials comprise 507 of 686 (74%) of CoreV2 genes
and 453 of 548 (83%) of Sanger core essentials, while 314 genes were common in all
approaches (Figure 2.12A). We also examined the gene expression profiles of these
core essential genes and observed that the 314 genes at the intersection of the three
approaches have higher median gene expression compared to genes that are
uniquely core essential in each approach (Figure 2.12B). These observations are
consistent with an increased false negative rate among essential genes with moderate
levels of mRNA expression as discussed in the previous section.
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Figure 2.12. Comparison of 992 common essentials with other “core essentials” show that
genes unique to each set show bias reflecting the library used. A) Venn diagram comparing
common essential genes to previously defined gold standard set of core essential genes. B)
Box plots showing the mean mRNA (TPM) expression of common core essentials (n=314),
genes unique to new common essentials identified here (n=346), Core V2 specific essentials
(n=142) and core essential genes specific to the Sanger dataset (n=58). C) Gene Ontology
(GO) biological process enrichment for core essential genes unique to a specific approach.
D) Comparison of the distribution of essentiality scores of Sanger specific core essentials in
common cell lines between the Avana and Sanger data.

Surprisingly, the core essential genes unique to each dataset showed a strong
bias reflecting the experimental approach used. We demonstrate that the genes
unique to common essentials defined in this study are highly enriched for essential
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processes including ribosome genesis and mRNA processing genes (Figure 2.12C).
Moreover, genes unique to CoreV2 show a strong bias towards genes encoding
subunits of the mitochondrial translation and electronic transport chain. As we
described in Figure 2.10 in section 2.3.4, dependency on these biological processes
is specific to the cancer subtypes in the dataset, and these genes are likely excluded
from the Sanger core essentials for the same reason. We did not observe any strong
functional enrichment among Sanger-specific core essentials, compared to the other
groups. Among 58 Sanger-specific core essentials, 14 were not targeted in the Avana
library and the remainder show intermediate BF scores in the 148 common highperforming Avana screens of the same cell lines (Figure 2.12D, red curve).
Collectively, these observations are consistent with there being a set of CRISPR
library-specific false negatives, as previously reported (Ong et al., 2017), which may
be independent of the expression-associated false negatives discussed in this work.

2.4 Discussion and conclusions
CRISPR technology has revolutionized the field of functional genomics,
providing an efficient method that leverages endogenous DNA repair machinery to
achieve gene knockouts on a whole genome scale. Compared to previous
technologies, CRISPR screens have been shown to detect 3-4 times more essential
genes at the same false discovery rate (Hart et al., 2014). Extensive use of this
technology by multiple independent groups has enabled screening of hundreds of
human cancer cell lines including the DepMap initiative, which is the main source for
the Avana data examined in this chapter. The vast amount of publicly available human
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cancer cell line data generated by these efforts enables an opportunity for reevaluating the assumptions under which these genome-scale experiments have been
carried out. One such assumption is that CRISPR screens are saturating and that a
well-designed single whole genome CRISPR-Cas9 knockout screen can virtually
detect all the essential genes in that background. However, this notion has not been
explicitly tested before and it is still poorly understood how the possible systematic
biases in CRISPR screens affect our understanding of human gene essentiality.
Furthermore, the true positive, false positive and false negative rates in an average
genome-wide CRISPR-Cas9 knockout screen are still unknown.

In this chapter, we demonstrated our modeling approaches to estimate the true
positive rate, false positive rate, and false negative rate from a typical genome-scale
CRISPR screen. Importantly, these analyses established a baseline for the expected
number of essential genes and the FDR in an average screen. The model which most
closely matches data from a large panel of CRISPR screens suggests that a typical
cell expresses 1,600-1,900 essential genes, but strikingly a single knockout screen
only detects ~80% of these, and multiple screens are required to saturate the essential
genes of any tissue or tumor subtype. We showed that hits among highly expressed
genes are often replicated but false negatives are more prevalent among genes
expressed at moderate levels. These observations carry severe implications for the
identification of differentially essential genes, in particular using isogenic cell lines to
identify synthetic lethal interactions, since it suggests numerous replicates need to be
screened in order to confidently discriminate cell-line-specific hits from false negatives
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and false positives. This knowledge is critical for evaluating the significance of findings
from current experiments as well as for the design of future experiments for gene
essentiality and synthetic lethality.

Another important implication of the false negative rate that we established is
that most tissue types carry a larger number of overlapping essential genes than had
been previously recognized in the field. After allowing for false negatives, we identify
nearly a thousand genes that are observed across all lineages that are deeply
sampled in the Avana screens. In contrast, we find only 300-600 tissue-specific genes
per lineage, with most showing overlap between related tissues. In fact, each tissue
only carries at most a few dozen tissue-unique genes, and these are enriched for
lineage-specific transcription factors.

Finally, with these analyses, we established a new set of core essential genes
and updated our daisy model of gene essentiality using a much more extensive
heterogeneous set of human cancer cell lines. This improved new set of core essential
genes are enriched in core essential processes of the cell and like the previous gold
standard set, can be used as a metric for the quality control of genome-wide CRISPRCas9 knockout screens. Comparing these newly defined genes to previously defined
gold standard core essential sets, we uncovered CRISPR library-specific false
negatives showing that a bias exists depending on the library used in these screens.
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Overall, the analyses in this chapter established some ground truths regarding
the expected number of essential genes, FDR and FNR in an average screen and
defined high-confidence sets of core and context essential genes, while revealing
important sources of bias in genome-wide CRISPR-Cas9 knockout screens.

2.5 Methods
2.5.1 Preprocessing of data with BAGEL
The raw read count file of genome-wide CRISPR pooled library screens for 769
cell lines using Avana library (Broad DepMap, 2020b; Meyers et al., 2017) (Broad
Institute’s DepMap Project 20Q2 release), the Avana data, was downloaded from the
data depository at https://depmap.org/portal/. Concurrently, data from 323 cancer cell
lines from the Sanger Institute’s Project Score (Behan et al., 2019) was downloaded
from the data depository at https://score.depmap.sanger.ac.uk/. Both datasets were
filtered in order to keep only the protein-coding genes for downstream analysis and
the gene names were updated using Human Genome Organization (HUGO) Gene
Nomenclature Committee (HGNC) (Braschi et al., 2019) and Consensus Coding
Sequence (CCDS) (Farrell et al., 2014) databases. sgRNAs targeting multiple genes
were discarded to avoid genetic interaction effects. The updated raw read counts were
processed with the CRISPRcleanR (Iorio et al., 2018) algorithm to correct for geneindependent copy number induced fitness effects and calculate fold change.
CRISPRcleanR uses a circular binary segmentation algorithm which was previously
used during the analysis for array-based comparative genomic hybridization assay

58
(Olshen et al., 2004; Venkatraman and Olshen, 2007) and applies it to genome-wide
CRISPR screens. For each individual chromosome, CRISPRcleanR detects regions
targeted by multiple sgRNAs with reasonably equal log fold changes (logFCs). If the
sgRNAs in these regions target a low number of unique genes, this would indicate
that the phenotype arises due to gene-independent effects and therefore the logFCs
are corrected through mean or median based centering depending on the presence
of outliers (Iorio et al., 2018). CRISPRcleanR processed fold changes of each cell line
were analyzed through updated BAGEL2 algorithm (Kim and Hart, 2021)
(https://github.com/hart-lab/bagel). Compared to the previous published version of
BAGEL (Hart and Moffat, 2016), the updated version of BAGEL employs a linear
regression model to interpolate outliers and uses 10-fold cross validation for data
sampling. BAGEL is a Bayesian classifier that is trained using previously defined gold
standard reference sets of core-essential and nonessential gene sets. BAGEL
estimates the distribution of fold changes of all gRNAs targeting all genes in either the
essential or nonessential training sets and then it calculates the log likelihood of
uncharacterized sgRNAs belonging to either the essential or nonessential
distributions and gives a log Bayes Factor (BF) as the final output (Figure 2.13).
Essentiality of each gene was measured as BF, which reflects the relative statistical
confidence of gene essentiality based on gold standard reference sets of 681 core
essential genes and 927 nonessential genes (Hart et al., 2017, 2014). Positive BF
indicates essential genes whereas negative BF indicates non-essential genes. The
list of gold standard core-essential genes and nonessential genes used in this
dissertation can be found in the same repository as the BAGEL v2 software. The
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qualities of each screen was evaluated through the “precision-recall” function of
BAGEL and the F-measure, which is the harmonic mean of the precision recall was
calculated for each screen at BF of 5. Finally, 659 cell lines for the Broad dataset and
316 screens for the Sanger dataset were selected for downstream analysis by an Fmeasure threshold of 0.80 to prevent noise from marginal quality of the screens.

A

B

Figure 2.13. Bayesian Analysis of Gene Essentiality. A) Kernel density estimate of the log
fold changes of guides targeting essential genes (red curve) and guides targeting
nonessential genes (blue curve). B) Histogram showing the distribution of Bayes Factors in a
screen with blue bars showing nonessential genes and red bars showing the essential genes.

2.5.2 Cumulative Essentials Analysis:
A cumulative analysis approach was used to evaluate and display the
cumulative distribution of essential genes and calculate the total number of true
essentials (true positives). As well as the error rate (FDR) in an average CRISPR-
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Cas9 knockout screen. This approach is based on the principle described previously
(Hart et al., 2014) that if you screen a sufficient number of cell lines with no false
positives, you would expect to see a cumulative essential genes observations plot that
flattens out with a slope of zero when the total number of essential genes is reached.
However, in reality, if you have some FDR or heterogeneity in the population of cell
lines being screened, the slope of the cumulative essential plot would stay positive.
This is because the true hits get saturated but in addition, it is likely that false positives
as well as cell-line specific context essential genes will also be captured and be added
on in each consecutive screen.

To perform the cumulative essentials analysis for the screens in the DepMap
project, herein referred to as the Avana data and the Sanger screens by Project Score,
the BFs for all genes across all cell lines was constructed in a separate matrix. For
each of the datasets, the cumulative essentials plot was modeled in any sets of 20
screens from the dataset. For example, for the Avana data, an initial set of 20 cell lines
were sampled without replacement and the essential genes in the first screen out of
20 were identified with a BF of greater than or equal to 10. Then the subsequent
screen was evaluated to obtain the essential genes in that screen and the newly
discovered essential genes that were not identified in the prior screen were added to
the list of essential gene hits to obtain a cumulative essential gene list. The process
was repeated for all 20 cell lines to capture all cumulative essentials in the 20 screens.
This random sampling process was repeated 100 times for each dataset to sample
different cell lines in different orders and prevent bias in the modeling process. The
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resulting mean cumulative essentials curves were plotted with standard deviations
reflecting the variability of cumulative essential genes observed in each of 100
iterations. Moreover, for each iteration, the newly discovered essential genes in each
set of 20 screens were also identified and displayed on the same plots.

2.5.3 Synthetic genome modeling approach
To estimate the number of essential genes per screen as well as the average
error rate, in silico simulations of synthetic screens were conducted. First, for each
dataset, a synthetic genome was constructed with the number of genes assayed in
that library (i.e. for Avana library N=18,111). For a given genome with N number of
genes in it, there is a number of true essential genes; represented by n, and number
of non-essential genes (N-n). Then, the precision (1 - FDR) of the assay is represented
by the ratio of true positives to that of the total number of hits. We defined a range of
thresholds for false discovery rate to test in our model from 1-15%. We then randomly
sampled this synthetic genome with a screen with randomly drawn 1287 hits for the
Avana dataset (the mean number of essential gene hits at BF>=10 across all Avana
screens) from the essential (n) and non-essential (N-n) populations based on the
defined FDR in the simulation (e.g. for 10% FDR, 129 nonessentials and 1,158
essentials were randomly selected) (Figure 2.14). We observed the cumulative
essential genes across 8 iterations since we estimated that sampling 8 screens was
a good estimate of observing the trend in screen saturation in the Avana data. At the
same time, we constructed a mean cumulative essentials curve determined from the
Avana data for any 8 screens using bootstrapping for 100 iterations. After running the
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simulations for a range of different number of essential genes (n) and FDR values,
cumulative observation curves were plotted for each simulation. The root mean
squared deviation for every synthetic screen was calculated by evaluating the
difference between the observed values and the cumulative essentials curve
determined from the Avana data (Figure 2.14).

Since both the Avana and Sanger data contains cell lines arising from multiple
tissue types, it is possible that some of the tissue specific essential genes would be
wrongly classified as false positives. Therefore, in order to minimize this effect, the
synthetic genome modeling approach was repeated for individual tissue types which
were represented by at least 16 high-quality cell lines (as defined by F-measure of
greater than or equal to 0.8) using the same parameters described above.

All of the analyses were performed using Python version 3.6 using multiple
packages including pandas (Reback et al., 2020), NumPy (Harris et al., 2020), the
sklearn.metrics, sklearn.utils, resample modules in SciKits (Buitinck et al., 2013),
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Matplotlib (Hunter, 2007), seaborn (Waskom et al., 2020) and scipy (SciPy 1.0
Contributors et al., 2020).

Figure 2.14: Overview of the synthetic genome modeling approach. A synthetic genome
with N=18111 genes were constructed and 1287 hits were randomly sampled from the
essential (n) and non-essential (N-n) populations based on the FDR in the simulation. The
resulting cumulative essential hits across 8 iterations were plotted and compared to the
mean cumulative essentials curve from the Avana data.

2.5.4 Saturation modeling approach and identification of high
confidence essential genes
While the in-silico simulations with synthetic genome model enabled an
estimation of the average number of essential genes per screen with an upper limit
for the FDR, they didn’t give information about which genes were truly essential. To
distinguish truly essential genes from false positives, the tissue types in the Avana
data that were well represented were identified (n>=16 screens). 18 tissue types in
the Avana data and 9 tissue types in Sanger data fit our criteria and for these tissue
types, the frequency of essential gene observations in any 8 screens was evaluated
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separately for each dataset. For each tissue type, a set of 8 initial screens were
selected, the cumulative essential genes in this set were identified and the frequency
of essentiality observations was plotted for this set. For the modeling, it was assumed
that if these first 8 screens have reached saturation (to approximate for our model),
then the subsequent hits in the next set of screens would give us false positives.
Therefore, a subsequent set of 8 screens from the same tissue type were randomly
selected without replacement and the newly discovered cumulative essential genes
that were not present in the initial screens were identified to model the frequency
distribution of the false positives. This process was repeated 100 times for each tissue
type in both datasets and the resulting distribution of essential gene counts in these
screens were plotted, which were used to calculate the bin-wise FDR. For the 100
iterations that were performed per tissue type, genes observed as essential in at least
3 screens on an average out of 8 were considered as high confidence essential genes
in that tissue. Finally, we assessed how many genes were captured as essential in
common in all tissues to find the set of “common” essential genes (n=954) and context
essentials in each tissue type. We used the UpsetR package (Conway et al., 2017) in
R programming language to visualize the set of intersections of essential genes
across all tissue types for both of the datasets.

2.5.5 Expression data and analysis
The log2 transformed RNA-seq TPM expression data was utilized from
DepMap Data Portal for the 2020Q2 release (Broad DepMap, 2020b) for this analysis.
The mean TPM expression levels were calculated for all genes in each bin in their
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corresponding cell lines in which the gene was a hit. The process was repeated for all
the bins from the histogram of the frequency of essentiality observations of the initial
set of 8 screens representing the true positives and the subsequent set of 8 screens
representing false positives.

2.5.6 Essentiality profiles of hits in non-essential screens
In this analysis, we evaluated the mean essentiality scores of genes
representing true positives in the screens that they were not observed as essential in.
For each iteration, we determined the screens in which genes in each bin had a BF
<10 and calculated a mean essentiality score for each gene in those screens. We then
visualized the distribution of mean essentiality score observations of genes in each
bin in the non-essential screens as a violin plot using the Seaborn package (Waskom
et al., 2017).

2.5.7 Process enrichment analysis for differentiating between
subtype specific genes vs false negatives

From our modeling of the number of essential genes and false positives per
tissue type, we had evaluated the frequency of essential gene observations in the 100
iterations we performed. We constructed a table of mean number of screen
essentiality observations out of 8 screens, in 100 iterations for every gene in each
tissue type. To investigate the trends of enrichment of essential pathways, we
measured the functional enrichment of gene annotations depending on the thresholds
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for the mean number of screens that a gene was observed as essential in in 0.5
increments (frequency out of 8 screens). For each threshold, we used the python
gseapy package version 0.9.11 (Subramanian et al., 2005) for python 3.8 (Van
Rossum, Guido and Drake, Fred L., 2009) to perform process enrichment in several
databases including KEGG, CORUM and GO Biological Process using all 18,111
genes assayed in the Avana library as the set of background genes. Going in 0.5
increments in the frequency of screen essentiality observations out of 8 screens, we
plotted the P-value of annotation enrichment for several terms to show the different
trends in the data. For every gene in the processes that were enriched, we calculated
their mean TPM expression in their corresponding cell lines for which the process
enrichment analysis was conducted. Finally, we evaluated the essentiality scores of
the genes in the enriched pathways in the corresponding cell lines where the mean
number of frequency of essentiality observation was greater than 0 out of 8 screens.
We used the seaborn.clustermap function of the seaborn package to plot the
hierarchically-clustered heatmap of the essentiality scores of the genes in each
pathway in the corresponding tissue type using the average linkage method and the
Euclidean distance metric.

2.6 Supplemental data
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Figure S2.1 Cumulative essential genes and newly discovered essentials in each
tissue type in the Avana data.
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Figure S2.2. Synthetic genome model applied to other tissue types in the Avana data. White
boxes indicate models within twice the minimum RMSD.
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Figure S2.3. Distribution of true positives and false positives in other tissue types in the
Avana data using saturation modeling approach.
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Table S1. Bin-wise FDRs for each tissue type in the Avana data using saturation modeling
approach.
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Chapter 3: Rescuing false negatives in genomewide CRISPR-Cas9 knockout screens
3.1 Abstract
The analyses in the previous chapter focused on establishing a baseline for the
expected number of essential genes and an average false discovery rate in an
average genome-wide CRISPR-Cas9 knockout screen. An important observation that
came out of these efforts was that the CRISPR screens are not saturating and that
there is a significant false negative rate that needs to be considered during the
analysis and interpretation of findings from such screens. Here we describe our
adjusted priors approach, which can not only rescue the false negatives but also be
utilized to discover subsets of cell lines that are preferentially dependent on
functionally coherent subgroups of genes.

3.2 Introduction
Detailed analyses for identification of essential genes through previously gold
standard methodologies such as the RNAi based genetic screening have revealed
false negatives mainly due to incomplete knockdown of the target genes that is
insufficient to induce a fitness defect in human cancer cells (Munoz et al., 2016).
Although the CRISPR technology enables more accurate and efficient targeting of
essential genes in genome-wide screens, potential false negative results from these
screens should be investigated to identify a complete set of essential genes in a given
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population. While we cannot theoretically measure the true false negative rate of
CRISPR screens since we do not know definite phenotype of every gene in a tissue
type, the false negative rate can still be estimated by taking alternative approaches.

In Chapter 2, we examined the cumulative essential genes in the Avana data
to show that while an average screen captures around 1250-1300 essential genes, it
takes multiple consecutive screens to identify the total population of essential genes
using our BAGEL derived essentiality scores (Figure 2.3). This finding also held true
for individual tissue types in the Avana data with our synthetic genome modeling
approach, where the expected number of truly essential genes in every tissue type
was more than the essential genes identifiable in one screen. These observations lead
to the conclusion that there is an unknown set of essential genes that we are failing to
detect in these screens, which we define as the false negatives in this chapter. (Figure
2.7). Moreover, with our saturation modeling approach, we demonstrated that the false
negatives are more prevalent among moderately expressed genes, leading to a bias
during the analyses (Figure 2.9; Figure 2.10) and these genes had to be repeatedly
screened in order to be captured as essential.

Previous studies also investigated the false negative rate in CRISPR screens.
A study compared data from cell lines screened by different libraries to estimate a
false negative rate of 14-23% in each library (Ong et al., 2017). This finding is
consistent with observations from our comparisons between core essential genes
defined by different approaches, where we had observed library-specific false
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negatives that are independent of the aforementioned false negatives in an average
screen.

Regardless of the source of this phenomenon, this chapter will take another
perspective to demonstrate with examples that a false negative rate exists in CRISPR
screens and then will describe a computational approach to correct for these genes.
Then we will discuss what kind of knowledge is added with the rescue of these false
negatives. Finally, we will show how we can utilize our computational method by
discovering subgroups of cell lines that are preferentially essential to subsets of genes
which how functional coherence.

3.3 Results
3.3.1 A single genome-wide CRISPR-Cas9 screen cannot detect all
essential genes in essential protein complexes
In the previous chapter, we demonstrated a significant false negative rate in an
average genome-wide CRISPR-Cas9 screen (Figure 2.7). Moreover, we also showed
that these false negative genes tended to be observed in an intermediate number of
screens in our saturation modeling approach. Here, we will expose the false negative
problem through essential protein complexes.

Previous studies in model organisms have shown that the individual subunits
of protein complexes tend to be either all essential or non-essential excluding cases
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where there might be functional buffering due to redundancy within the complex
members (Ryan et al., 2013). This notion leads to a model where essential protein
complexes are formed by essential genes whereas non-essential complexes are
formed by non-essential genes. Therefore, in human protein complexes, if a complex
has essential functions, we expect to see all members of that complex to be
collectively and entirely essential unless there is functional buffering. To see if the
same trend exists in the Avana data, we looked at previously defined essential protein
complexes to see how our BAGEL algorithm detects individual essential genes.

The proteosome is a large, essential protein complex responsible for degrading
intracellular proteins (Tanaka, 2009) and we expect this complex to be essential in all
cell lines since it carries a core-essential function. In Figure 3.1A, we see the binary
essentiality calls (where BF>=10 is considered as essential) of the members of the
26S proteosome complex as defined in the Comprehensive Resource of Mammalian
Protein complexes (CORUM) database (Giurgiu et al., 2019) among colorectal cancer
cell lines in the Avana data. We observed that each individual screen is unable to
capture all of the individual members of this complex as essential although the
proteosome is an essential complex. Similarly, in Figure 3.1B, we see the binary
essentiality calls of the members of another essential, evolutionarily conserved COP9
signalosome complex which plays a role in controlling protein ubiquitinylation
(Gutierrez et al., 2020) among Avana colorectal cancer cell lines. Again, we observe
that not all screens can identify members of this complex as essential. In this complex,
we don’t observe COPS7A and COPS7B as essential in any screen since as we have
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previously shown, COPS7A and COPS7B are synthetic lethal paralog pairs and they
encode alternate, replaceable subunits of the complex, while the other subunits are
irreplaceable and are uniformly essential (Dede et al., 2020a).

B

A

Figure 3.1. Binary essentiality calls of essential protein complexes among colorectal cancer
cell lines in the Avana data based on BAGEL derived essentiality scores. Dark blue color
indicates essentiality (BF>=10) and white color indicates non-essentiality (BF<10). A) Binary
essentiality calls of members of 26S proteosome complex. B) Binary essentiality calls of
members of COP9 signalosome complex among colorectal cancer cell lines in the Avana data
based on BAGEL derived essentiality scores.

Based on these observations, we proposed that during the analysis of genomewide CRISPR-Cas9 knockout screens, in every screen, there is an unknown set of
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essential genes that we are failing to detect as essential, leading to a significant false
negative problem.

We first questioned whether this false negative rate arises due to underlying
screen quality. Even though we only considered high-performing screens with Fmeasure > 0.80 in our analysis, we plotted the F-measure of each screen versus the
number of non-essential hits within the complex for both the proteosome and COP9
signalosome complexes. We observed a trend where the screens with lower Fmeasures tended to exhibit a higher number of non-essential hits (BF<10) within these
essential complexes (Figure 3.2).
A

B

Figure 3.2. The relationship between screen quality (F-measure) and the number of nonessential hits within essential protein complexes. Boxplots showing the distribution of Fmeasures of screens versus the number of times a non-essential call was made among
members of proteosome complex (A) and COPS9 signalosome complex (B).
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Besides screen quality, we also questioned whether there are library-specific
false negative protein complexes. As we discussed in section 2.3.6 and in Figure
2.12D, our saturation modeling had demonstrated that there could be CRISPR-library
specific false negatives. Comparing the Sanger and Avana datasets, we observed that
this phenomenon indeed exists as shown for the MCM complex, which is an essential
complex regulating DNA replication in eukaryotic cells Figure 3.3 (Lei, 2005). While
multiple Avana colorectal screens fail to capture members of this essential complex
(based on binary essentiality calls with BAGEL derived BF>10), Sanger colorectal
screens show more consistent essentiality calls for members of the same complex,
indicating that library-specific false negatives also exist.
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Figure 3.3. MCM complex is an example of a CRISPR-library specific false
negatives. While some members of the MCM complex cannot be captured as
essential in multiple colorectal screens in the Avana dataset (left), the complex
shows more uniform essentiality in Sanger colorectal cell lines (right).

3.3.2 Overview of the adjusted-priors approach
Having shown that the false negatives exist in CRISPR-Cas9 screens, we
sought to develop a method to correct for these genes. Before we introduce our
computational method, we would like to go into some detail on our in-house developed
BAGEL algorithm. BAGEL is a Bayesian classifier that is trained using pre-defined
gold standard reference sets of core-essential and nonessential gene sets. BAGEL
first estimates the distribution of fold changes of all gRNAs targeting all genes in either
the essential or nonessential training sets and then calculates the log likelihood of
uncharacterized sgRNAs belonging to either the essential or nonessential
distributions. The final output of BAGEL is a log Bayes Factor (BF) which represents
the relative statistical confidence of gene essentiality. The statistical representation of
BF can be seen with the equation below:
𝐵𝐵𝐵𝐵 =

Pr(𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷|𝐸𝐸𝐸𝐸𝐸𝐸)
Pr(𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷|𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁)

This equation can be converted as follows by adding a prior ratio:
𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜 =
𝑤𝑤ℎ𝑒𝑒𝑒𝑒𝑒𝑒

Pr(𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷|𝐸𝐸𝐸𝐸𝐸𝐸)
Pr(𝐸𝐸𝐸𝐸𝐸𝐸)
∙
Pr(𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷|𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁) Pr(𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁)

Pr(𝐸𝐸𝐸𝐸𝐸𝐸) + Pr(𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁) = 1

Performing log transformation, we get:
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𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 log 𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜 = log(𝐵𝐵𝐵𝐵) + log(𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝 𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟)
Based on prior information from genome-wide CRISPR-Cas9 knockout
screens regarding the number of essential genes in a given genome, we consider
Pr(𝐸𝐸𝐸𝐸𝐸𝐸) = 0.1 (ie. the background expectation of gene essentiality in humans is 10%),
which yields Pr(𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁) = 0.9 and therefore we have:
log(𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝 𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟) = log �

Pr(𝐸𝐸𝐸𝐸𝐸𝐸)
�= ~−3
Pr(𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁)

While using our BAGEL algorithm, we traditionally use this flat prior ratio of -3
during BF calculations for all screens. In order to rescue the false negative genes we
observed during our analysis, and to differentiate between false negative genes and
subtype-specific genes, we employed an alternative method called adjusted priors
approach. In this approach, instead of using a flat prior of -3 for all screens, we update
this prior ratio as we gain observations from the screens. And instead of using
essentiality scores, BFs for each gene, we assigned a binary call to each gene based
on posterior probability of essentiality, after updating the probability of essentiality of
each screen based on prior observations.

First, we revisited our saturation modeling approach described in 2.3.3, where
we evaluated sets of 8 initial and 8 subsequent screens to model the distribution of
true positive essential genes and false positives to calculate a bin-wise FDR for each
of the 8 bins.
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Specifically, we evaluated sets of 8 screens at a time in each tissue type. For
each gene, we ranked the screens from the highest BF to lowest in each set. Next, for
the top cell line in which the gene had the highest BF, we calculate the posterior
probability of essentiality for that gene. Since we don’t have any prior data for the
observations for this screen, we use the initial log prior ratio of -3 and assign a binary
call of essentiality of 1 if the BF >10 based on posterior log(odds) of 7 which
corresponds to a posterior Pr(ess) of 99%. We chose a strict posterior log odds ratio
of 7 to have high confidence binary essentiality calls with posterior Pr(ess) ~99% in
our analysis. Next, we move on to the next screen if the screen gets an essential
binary call in the first screen, For the next screen where the gene has the second
highest BF, the prior is now based on having observed this gene as essential in the
previous screen assuming that these screens are related. And for the log prior ratio,
instead of using Pr(Ess) of 0.1 and Pr(Noness) of 0.9, we use the bin-wise FDR values
from the saturation modeling approach (Table S1). Given an observation of having
this gene as essential in 1 screen, we questioned the probability of whether this is a
true observation. Using the corresponding bin-wise FDR belonging to a tissue, for this
1−(𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏 𝐹𝐹𝐹𝐹𝐹𝐹 𝑖𝑖𝑖𝑖 𝑏𝑏𝑏𝑏𝑏𝑏1)

second cell line, we substituted the log(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟) with log(
example, if the bin-wise FDR is 50% for the first bin, we get:

log(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟) = log �

(𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏 𝐹𝐹𝐹𝐹𝐹𝐹 𝑖𝑖𝑖𝑖 𝑏𝑏𝑏𝑏𝑏𝑏1)

1 − (0.5)
�=0
(0.5)

Again, using a log odds ratio of 7 to ensure 99% probability of essentiality:

). For

81
𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 log 𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜 = log(𝐵𝐵𝐵𝐵) + log(𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝 𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟)
7 = log(𝐵𝐵𝐵𝐵) + 0

Therefore, a BF>7 will indicate that the probability of essentiality is ~99%,
resulting in a binary call of essentiality of 1. If the gene is again assigned as an
essential gene, then this process goes on for the third screen, using the bin-wise FDR
values from the second bin in the saturation modeling approach. The assignment of
binary calls end once all 8 screens are evaluated. Since the bin-wise FDR values are
almost negligible for certain bins as we have shown in the saturation modeling
approach, we capped the prior log ratio at 9 so that the BF threshold does not become
too low while ensuring high probability of essentiality. In addition, to ensure that all cell
lines are properly sampled, we repeated the sampling process 100 times, selecting 8
different screens in each iteration from every tissue type to minimize bias. For every
tissue type, we recorded all binary calls for all genes in 100 iterations as well as the
cell lines that were sampled in each iteration.

3.3.3 Adjusted priors approach identifies a higher number of
essential genes without a drastic increase in the number of false
positives
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After applying our adjusted priors approach to all tissue types in the Avana and
Sanger data, we compared the observations in both datasets to our saturation
modeling approach to evaluate how the bin-wise distributions of hits changed. We
observed that the adjusted priors approach resulted in a rightward shift towards a
higher frequency of gene essentiality calls, with lower number of hits in the first bins
and much higher number of hits in the eighth bin compared to the saturation modeling
approach (Figure 3.4A for Avana data). Genes that had a higher frequency of
observations (6 or higher out of 8) were skewed towards the eighth bin while the genes
that were in the lower frequency bins (enriched in false positives) were not boosted to
higher bins with our adjusted priors approach. We observed a similar trend in the
Sanger dataset as well (Figure S3.1).

Figure 3.4. Adjusted priors approach identifies more essential genes in Avana genome-wide
CRISPR-Cas9 knockout screens compared to saturation modeling approach. A) Comparison
of the frequency of essential gene hits in saturation modeling versus adjusted priors approach.
B) Comparison of violin plots showing the distribution of the essentiality scores (Bayes Factor,
BFs) of the hits in A, in the screens where they were not observed as essential.
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During our analyses in our saturation modeling approach, we had evaluated
the essentiality scores of the hits in the screens that they were not essential in. We
had observed that the more frequently a gene is captured as essential, the higher its
average BF was in screens where it is not essential Figure 2.9C. This observation
was strongly consistent with false negatives. Therefore, we performed the same
analysis after applying our adjusted priors approach to see if we could rescue the
trend we observed in saturation modeling. As shown in Figure 3.4B, we observed that
hits in our adjusted priors approach tended to have consistently negative BFs in the
screens that they were not essential in indicating that the false negatives have been
rescued.

One question that arises from our adjusted priors approach is whether the false
positive rate also increases as we rescue false negatives in our screens. To determine
if this is the case, we compared the number of hits as well as the number of false
positive genes detected across colorectal cancer cell lines in Avana data when binary
essentiality calls are made using a BF threshold of 10 vs BF of 5 and a mean adjusted
priors call of 1 across all iterations in that cell line. The false positive genes were
defined based on CCLE log(TPM) expression <1 in a given cell line. We observed that
adjusted priors method detects a significantly higher number of essential gene hits
compared to a binary called based on BF>10 (t-test ind. samples with Bonferroni
correction, p-value=6.989e-05), while lowering the BF threshold to 5 results in a nonsignificant increase in the number of hits compared to adjusted priors method (Binary
BF5 vs. Adj. priors: t-test ind. samples with Bonferroni correction, p-value=7.904e-02)
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(Figure 3.5A). Moreover, we observed that although the number of false positives
detected with adjusted priors (mean=50) is higher than those detected with binary
calls using BF>10 (mean=38) in colorectal cancer cell lines (t-test ind. samples with
Bonferroni correction, p-value=1.114e-02), the increase is still less significant
compared to the number of false positives obtained after lowering the BF threshold to
5 (mean=77, Binary BF10 v.s. Avana_binary_BF5: t-test ind. samples with Bonferroni
correction, p-value=2.082e-07)(Figure 3.5B). These findings indicate that the adjusted
priors method can detect more essential genes thus recuing false negatives without a
drastic increase in the number of false positives detected per screen compared to
lowering the BF threshold to 5.

Figure 3.5. Adjusted priors can rescue the false negatives with a less significant
increase in false positives compared to assigning binary calls using a lower BF
threshold. A) The number of essential gene hits using binary calls indicated by
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different thresholds indicated on the x axis. B) The number of false positive genes
detected across colorectal cancer cell lines in the Avana data using different
thresholds indicated on the x axis. P-value annotation legend as follows; ns: 0.05 <p,
*: 0.01< p <=0.05, **:0.001< p <=0.01, ***: 0.0001 < p <= 0.001.

3.3.4 Adjusted priors rescues false negatives, increasing the
enrichment of essential processes among high frequency hits
Next, we investigated the number of false negatives we rescued in a bin-wise
fashion using our adjusted priors approach. After calculating the mean adjusted priors
essentiality calls out of 8 screens for 100 iterations, we plotted the delta shift in the
frequency of observations out of 8 screens with the adjusted priors approach versus
the saturation modeling frequencies. We observed that the genes in lower frequency
of observations (lower bins) in saturation modeling approach tended to display low
delta bin values, staying in lower bins and indicating that their frequency observations
are not boosted by our approach (Figure 3.6). However, genes in high frequency bins
(bin 5 and higher in saturation modeling approach) tended to show a higher delta and
get boosted to the eighth bin in the adjusted priors approach (Figure 3.6).
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Figure 3.6. Delta-shift in frequency of observations out of 8 screens with adjusted
priors approach (y-axis) compared to saturation modeling approach (x-axis) for the
colorectal cancer cell lines in the Avana data. Red line indicating bins which comprise
the false negative genes.

For our downstream analysis, we defined false negative genes as the ones that
were assigned to the eighth bin (mean essentiality frequency >=7.5 out of 8 screens
with adjusted priors) excluding those that were already in the eighth bin in the
saturation modeling approach in each tissue type (indicated by the red diagonal line
in Figure 3.6 for colorectal cancer cell lines in the Avana data as an example). We
also repeated the same process for the Sanger dataset. First, we evaluated whether
these false negative genes contained any members of the essential protein complexes
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we showed in section 3.3.1 Figure 3.1. We observed that our adjusted priors approach
rescued several members of the proteosome and COPS complexes (false negative
genes indicated by orange boxes) which were previously missed in individual screens
(Figure 3.7).
A

B

Figure 3.7. Adjusted priors approach rescues previously missed false negative genes
in essential protein complexes. Binary essentiality calls based on BAGEL derived
BF>=10 of proteosome complex (A) and COPS complex (B) among colorectal cancer
cell lines in the Avana data. The false negative genes rescued with the adjusted priors
approach are indicated with orange boxes for both protein complexes.
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Next, we questioned whether the false negatives that we have observed and
rescued with our adjusted priors approach is a general phenomenon or a library
specific problem. We evaluated the overlap of the false negatives we identified in the
Avana and Sanger screens, high frequency hits in the eighth bin in both datasets as
well as the overlap obtained when the false negatives are combined with the high
frequency hits. As shown for the colorectal cancer cell lines in the Avana and Sanger
datasets in Figure 3.8, we observed that while the false negatives in both datasets
alone and the high frequency hits in the saturation modeling approach (eighth bin)
alone had partial overlap, the combination of these two groups merged the datasets
closer together.
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Figure 3.8. False negatives are not a library-specific phenomenon. Top-left: Venndiagram showing the overlap of the false negative genes among colorectal cancer cell
lines in Avana and Sanger datasets. Top-right: The overlap of genes with high
frequency observations (bin 8) in saturation modeling approach among colorectal
cancer cell lines in both datasets. Bottom: Combination of false negative genes with
high frequency hits in saturation modeling approach in both datasets.

We then investigated whether the rescued false negatives are involved in the
same pathways as the high frequency hits. We performed process enrichment for the
sets shown in Figure 3.8 and observed that the false negative genes indeed increase
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the enrichment of the essential processes among high frequency hits in the saturation
modeling approach. This indicates that more members of these essential pathways
are captured with the addition of false negatives resulting in a more comprehensive
set of high confidence, high frequency hits in both datasets (Figure 3.9).

Overall, these analyses show that our adjusted priors approach is able to
rescue false negative genes from essential pathways and improves the concordance
between the Avana and Sanger datasets.
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Figure 3.9. The recovered false negatives increase the enrichment of essential
biological processes in colorectal cell lines among high frequency hits defined in
saturation modeling approach. Top: Avana colorectal cell lines. Bottom: Sanger
colorectal cell lines. Blue bars indicate the enrichment among high frequency hits in
saturation modeling and orange bars depict the increase in enrichment with the
addition of false negative genes.
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3.3.5 Adjusted priors approach can detect sub-groups of cancer
cell lines that are preferentially dependent on functionally coherent
groups of genes
Finally, we investigated whether the binary essentiality calls we made through
the adjusted priors approach can be used to provide any insights into detecting cancer
subtype specific modules. Since our adjusted priors approach evaluates essentiality
across 8 sampled screens at a time within a tissue type, we had to take an alternative
approach in order to obtain cell line specific assignments. We converted these tissue
level scores (frequency of observation out of 8 screens) to cell line specific
assignments by calculating the total number of times a binary call of 1 (indicating the
gene is essential) was made for each gene in each cell line across 100 iterations and
then normalizing by how many times that cell line was chosen in our 100 iterations.
With this method, we obtained a normalized binary essentiality call at a cell line level
that ranged from 0 to 1 for each gene.

Next, we used these normalized calls to look for subsets of cell lines of the
same tissue type that are preferentially essential to subsets of genes to look for
functionally coherent modules. After removing genes that were consistently
nonessential and highly essential across all cell lines within a tissue type, we
performed hierarchical clustering of the cell lines to observe whether the clusters
would represent cancer specific subtypes.
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We first evaluated at the colorectal cancer cell lines in the Avana data and
clustered the genes based on their normalized adjusted priors calls. We also added
the Consensus Molecular Subtypes (CMS) of colorectal cancer information as defined
previously (Guinney et al., 2015).

Figure 3.10. Hierarchical clustering of colorectal cancer cell lines and genes with
mean normalized adjusted priors calls between 0.3 and 0.7. The colorectal cancer cell
lines are color coded using the CMS subtyping.

The CMS classification was previously defined to integrate gene expression
profiles of colorectal carcinoma samples from different stages. It is divided into four
subtypes from CMS1 to CMS4 where each of the subtypes are thought to represent
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a characteristic molcular profile. For example the CMS1 tumors exhibit strong immune
acivation and higher mutation rates, CMS2 tumor show a typical Beta catenin
activation representign epithelial cancers while the CMS3 shows dysregulation of
metabolic genes and CMS4 represent mesenchymal tumors with poorest survival
(Thanki et al., 2017).

As seen in Figure 3.10, using our normalized adjusted priors calls, the
colorectal cancer cell lines in the Avana data clustered into separate groups with
mainly CMS2 and CMS4 cell lines clustering separately from CMS1 and CMS3. We
noticed that a gene cluster in the plot seemed to be roughly essential in about half of
the cell lines, therefore we sought to explore whether these genes were enriched in a
particular pathway.

A closer examination of this cluster with process enrichment showed that the
cell lines mainly separated into two groups based on the essentiality profiles of a
subgroup of genes enriched in mitochondrial translation related pathways (Figure
3.11).
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Figure 3.11. Gene cluster enriched in mitochondrial translation pathway among
colorectal cancer cell lines in Avana data. Top: Hierarchical clustering of the colorectal
cancer cell lines bases on mean normalized adjusted priors calls of the gene cluster.
Bottom: Process enrichment of genes in cluster using GO Biological Process 2018 gene
sets.
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Our analysis showed that the genes involved in the mitochondrial translation,
respiratory chain signal and related pathways appeared in every tissue type and was
suppressing the other phenotypes in the data. We therefore questioned whether these
processes are due to another source of bias in the data. We obtained the doubling
times of the CCLE cell lines and looked at the relationship between the essentiality
scores of the genes involved in the aforementioned pathways and doubling hours of
the cell lines in CCLE. We observed that the mean Bayes factors of the genes involved
in these processes are negatively correlated to the doubling times of the cell lines
indicating that the phenotype we are observing is due to a bias related to the growth
rate, creating a source of noise in the data (Figure 3.12).

Figure 3.12. Cellular doubling times are a source of bias towards genes related to
mitochondrial translation related processes in the data.
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To mitigate for this effect, we removed genes related to mitochondrial
translation and oxidative phosphorylation related pathways and performed clustering
again in order to find subsets of cell lines that are preferentially dependent on
functionally coherent gene groups. Among colorectal cancer cell lines, we observed
that while the CMS1 and CMS3 cell lines are dependent on a group of genes enriched
in tRNA processing and tRNA modification pathways, the mesenchymal CMS4 cells,
which have poor prognosis, do not exhibit the same dependency on this subgroup of
genes (Figure 3.13).
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Figure 3.13. CMS1 and CMS3 colorectal cancer cell lines show preferential dependence on
tRNA processing and tRNA modification pathways while the CMS4 subtype does not show
a similar dependency. Top: Hierarchical clustering of the colorectal cancer cell lines using
the mean normalized adjusted prior calls of genes indicated on y-axis. Bottom: Process
enrichment of genes in clusterogram using GO Biological Process 2018 gene sets.
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Similarly, we evaluated the breast cancer cell lines to discover if the cell lines would
cluster based on previously defined breast cancer subtypes. Again, after removing
mitochondrial translation and related genes, we observed that that the more
differentiated luminal and HER2 amplified breast cancer cell lines clustered separately
from the basal subtypes using our adjusted priors calls (Figure 3.14).

Figure 3.14. Breast cancer cell lines in Avana. Luminal and HER2 amplified cell lines form
their own cluster while the basal subtypes cluster separately. Cells lines are color coded
according to the breast cancer subtypes defined in the DepMap project.
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We then zoomed into some of the trees observed in Figure 3.14, and demonstrated
the differential essentiality of the luminal and HER2 amplified subtypes on estrogen
pathway and G2/M transition while the basal subtype breast cancers do not show any
dependence to this subgroup of genes (Figure 3.15).
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Figure 3.15. Luminal and HER2 amplified cell lines are dependent on a subset of genes
involved in G2/M transition and estrogen receptor signaling pathway. Top: Hierarchical
clustering of breast cancer cell lines in Avana using the mean normalized adjusted priors
calls of a group of genes. Bottom: Process enrichment of genes in the above cluster.

Another cluster we observed belongs to a group of genes that are enriched in integrin
mediated signaling pathway that controls metastasis and which is preferentially
essential in highly metastatic basal b triple negative breast cancer cell lines (Figure
3.16).
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Figure 3.16. Subset of breast cancer cell lines show differential essentiality for a group of
genes enriched in integrin mediated signaling pathway. Top: Hierarchical clustering of breast
cancer cell lines in Avana using the mean normalized adjusted priors calls of a group of genes.
Bottom: Process enrichment of genes in the above cluster.
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We made another interesting observation in the lung tissue, where we see a
group of non-small cell lung adenocarcinoma cell lines being dependent on
peroxisomal and fatty-acid oxidation genes (Figure 3.17). In this cluster we show the
differential essentiality of ACOX1 and HSD17B4 genes which carry out the enzymatic
steps in the process of peroxisomal fatty acid oxidation. Moreover, we also observe
several PEX genes which are responsible for peroxisome biogenesis.
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Figure 3.17. A group of non-small cell lung adenocarcinoma cell lines exhibit differential
essentiality for genes involved in peroxisomal and fatty acid oxidation pathways. Top:
Hierarchical clustering of lung cancer cell lines in Avana using the mean normalized adjusted
priors calls of a group of genes. Bottom: Process enrichment of genes in the above cluster.
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Interestingly, these observations are consistent with our findings from our
human co-essentiality network (Kim et al., 2019). In this work, we had constructed a
network of genes with correlated essentiality scores and showed that these correlated
fitness profiles could be used to infer shared biological function since they are
analogous to having correlated genetic interaction profiles. With our network, we were
able to identify clusters of genes with functional coherence using gene co-essentiality
profiles. One such example was the peroxisomal beta-oxidation cluster that is
depicted in Figure 3.18A which contains several genes involved in peroxisomal fatty
acid beta oxidation and peroxisome biogenesis (Figure 3.18B). The members of this
cluster show a pattern of differential co-essentiality in 6 out of 42 lung cancer cell lines
in the earlier release of the Avana data (Figure 3.18C), consistent with our
observations from our independent data driven approach.
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Figure 3.18. Peroxisome cluster in the human co-essentiality network. A) A group of genes
involved in peroxisome (orange) is inter-connected with edges that show high correlation
(blue) in the human co-essentiality network. B) Genes in the PEX cluster are composed of 12
genes with two enzymes responsible for fatty acid oxidation reactions and 10 other genes
involved in peroxisomal biogenesis and maintenance. C) The PEX cluster in the coessentiality network shows differential essentiality in a subset of lung cancer cell lines in the
initial release of Avana data. (E. Kim, M. Dede, W. Lenoir, G. Wang, S. Srinivasan, M. Colic,
T. Hart, A network of human functional gene interactions from knockout fitness screens in
cancer cells. Life Sci Alliance, 2019. 2(2). Figure used with permission from Eiru Kim, Ph.D.
Copyright permissions are not required. This article is available under a Creative Commons
License – https://creativecommons.org/licenses/by/4.0/).
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3.4 Discussion and conclusions
CRISPR-Cas9 technology has proven to be to be the gold standard method to
detect essential genes, discovering a significantly increased number of essentials
compared to previous technologies at the same false discovery rate. Using this
technology to conduct whole genome screens in hundreds of cancer cell lines, we and
others have identified cancer specific essential genes. However, in practice, each lab
does not perform experiments in a large number of screens. Although biological and
technical replicates are routinely included, it is impractical for each experiment to be
conducted in hundreds of cell lines or with dozens of replicates. Therefore, it is crucial
to know about the limitations during the analysis of experiments conducted with this
technology, especially when driving conclusions from experiments performed in a
limited number of screens.

During our extensive analysis of cell lines from both the DepMap project and
Project Score, we demonstrated a significant false negative problem during the
analysis of whole genome CRISPR-Cas9 knock out screens. As shown with the core
essential protein complexes which are expected to be composed of essential genes,
a single screen in a cell line is unable to detect all members of these essential
complexes. This indicates that a single experiment cannot detect all essential genes
in that background, which creates a limitation during the interpretation of the results
from these screens.

108
In order to address this significant limitation and to improve our understanding
of gene essentiality, we developed our adjusted priors approach. In this method,
instead of using a flat prior based on the background probability of a gene being
essential as 10%, we updated this prior ratio based on the previous observations we
made from the saturation modeling approach of the Avana data where we had
established bin-wise false discovery rates for each frequency of essentiality
observations across multiple tissue types. Using these updated priors, for each gene
we calculated the posterior probability of essentiality and assigned a binary
essentiality call instead of continuous mapping with Bayes factors.

Our method resulted in an increased number of genes with high frequency
observations, thus a greater number of high confidence essential genes when we
compared the outcomes of the adjusted priors with saturation modeling approach
(Figure 3.4A). Moreover, the essentiality profiles of the hits in non-essential screens
showed negative Bayes factors, indicating that these genes were indeed nonessential in those screens (Figure 3.4B). With our analysis among the essential
protein complexes, we showed that our adjusted priors approach was able to rescue
several false negative genes which appeared to be deemed non-essential in individual
screens using binary calls made using BAGEL derived BF>=10 threshold (Figure 3.7).
These findings carry significant implications for the identification of the total population
of essential genes in a given context as they suggest that our computational method
offers a cleaner analysis of the data, correcting for the previously unidentified false
negatives.
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By evaluating the shift in observations of the adjusted priors with saturation
modeling, we defined the false negative genes in each tissue type. We observed that
the addition of false negatives to the highest frequency hits (8 out of 8 screens)
increased the enrichment of essential processes demonstrating that more members
of these essential processes were captured using adjusted priors. Furthermore, the
application of this method to both the Avana and Sanger datasets increased the
number of common hits between the observations in these two independent
approaches, resulting in a higher concordance between the datasets.

Fortunately, the detection of a greater number of essential genes with adjusted
priors does not come with an unwanted side effect of a detrimental increase in the
number of false positives. Compared to the number of essentials detected with
different BF thresholds, adjusted priors detects significantly more essentials than
those with BF>10, while lowering the threshold to BF>5 does not cause a significant
increase than the adjusted priors (Figure 3.5). Strikingly, the mean number of
essential genes detected with adjusted priors among colorectal cancer cell lines
(N=1565) is approximately what we had predicted in section 2.3.2 using our synthetic
genome modeling for the same tissue type (N=1600) (Figure 2.6), indicating the
consistency of our findings using different approaches.

Furthermore, the utility of the adjusted priors approach goes beyond
addressing the false negative problem. Besides uncovering the false negatives in
each tissue type, adjusted priors approach can distinguish cancer subtypes in a
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modular fashion. We applied our method to identify subgroups of cell lines that exhibit
preferential essentiality to subsets. We observed that indeed clusters of cell lines,
which corresponded to previously defined cancer subtypes showed dependence of
gene sets which showed functional coherence. Our examples in multiple tissue types
indicate that our data driven approach can discriminate between false negatives
versus subtype specific essential genes which are highly essential in a subgroup of
cell lines.

Our lab has previously constructed the coessentiality network from human cell
lines where genes with correlated essentiality scores are used to infer correlated
genetic interaction profiles (Kim et al., 2019). With the coessentiality network, we were
able to identify clusters of coessential genes that are functionally coherent. However,
the coessentiality network does not address the question of what subtypes are present
since the purpose of the network was to infer gene function. In this work, using an
independent approach, our adjusted priors method enabled us to investigate genes
that are essential in some fraction of cells and are functionally coherent within those
groups regardless of their coessentiality. Ultimately, we were able to find modules that
are consistent with observations from the coessentiality network, with subsets of cell
lines that are preferentially essential to sets of genes which show functional
coherence. Thus, our method offers an avenue for data driven discovery of subtypes
within a tissue, based solely on their essentiality profiles.
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3.5 Methods
3.5.1 Preprocessing of data with BAGEL
The Avana dataset processing was performed using the same methodology
described in section 2.5.1 to obtain BAGEL derived essentiality scores for each gene
in every screen.

3.5.2 Adjusted-priors approach
In order to explain the methodology behind our adjusted priors approach, we
need to re-visit some details about our BAGEL algorithm. The output of BAGEL is
the Bayes factor (BF), the statistical representation of which can be displayed with
the equation below:
𝐵𝐵𝐵𝐵 =

Pr(𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷|𝐸𝐸𝐸𝐸𝐸𝐸)
Pr(𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷|𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁)

The BF allows the transform to posterior odds and therefore enables the
conversion of these scores to a probability of essentiality which in turn allows us to do
a binary classification of gene essentiality instead of continuous mapping. Therefore
the posterior odds can be obtained by multiplying the BF with the prior ratio as shown
below:
Prior ratio

𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜 =
𝑤𝑤ℎ𝑒𝑒𝑒𝑒𝑒𝑒

Pr(𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷|𝐸𝐸𝐸𝐸𝐸𝐸)
Pr(𝐸𝐸𝐸𝐸𝐸𝐸)
∙
Pr(𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷|𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁) Pr(𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁)

Pr(𝐸𝐸𝐸𝐸𝐸𝐸) + Pr(𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁) = 1
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Performing log transformation, we get:
𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 log 𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜 = log(𝐵𝐵𝐵𝐵) + log(𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝 𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟)
Based on prior information from genome-wide CRISPR-Cas9 knockout
screens regarding the number of essential genes in a given genome, BAGEL
considers

Pr(𝐸𝐸𝐸𝐸𝐸𝐸) = 0.1 (ie. the background expectation of gene essentiality in

humans is 10%), which yields Pr(𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁) = 0.9 and therefore we have:
log(𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝 𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟) = log �

Pr(𝐸𝐸𝐸𝐸𝐸𝐸)
�= ~−3
Pr(𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁)

The relationship between the posterior probability of essentiality and BFs can
be seen in the figure below (Figure 3.19). And as Table 1 indicates, Bf of 10
corresponds to a posterior probability of essentiality of ~99% and that is why we used
this strict threshold for identifying essential genes through this entire dissertation.

Figure 3.19. Relationship between posterior probability of essentiality and Bayes
Factor thresholds.
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Table 1. Bayes factors vs the posterior probability of essentiality.

During BF calculations with our BAGEL algorithm, we traditionally use this flat
prior ratio of -3 for all screens. However, our adjusted priors method relies on the
notion that this prior ratio gets updated as we gain more observations from the
available data. The final outcome is a binary essentiality call for each gene based on
the posterior probability of essentiality instead of a BF.

First, we revisited our saturation modeling approach described in 2.3.3, where
we evaluated sets of 8 initial and 8 subsequent screens to model the distribution of
true positive essential genes and false positives to calculate a bin-wise FDR for each
of the 8 bins. Specifically, we evaluated sets of 8 screens at a time in each tissue type.
For each gene in this set, we ranked the screens from the highest BF to lowest. Next,
for the top cell line in which the gene had the highest BF, since we don’t have any
prior data for the observations for this screen, we used the initial log prior ratio of -3
and assigned a binary call of essentiality of 1 if the BF >10 based on posterior
log(odds) of 7 which corresponds to a posterior Pr(ess) of 99%. Throughout the
analysis, we kept this strict posterior log odds ratio of 7 to have high confidence binary
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essentiality calls with posterior Pr(ess) ~99%. Next, for the second screen where the
gene had the second highest BF, the prior is now based on having observed this gene
as essential in the previous screen assuming that these screens are related (ie the
cell lines from the same tissue types). And we used information from the the bin-wise
FDR values we calculated from the saturation modeling approach. Therefore, using
the corresponding bin-wise FDR belonging to a tissue, for this second cell line, we
1−(𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏 𝐹𝐹𝐹𝐹𝐹𝐹 𝑖𝑖𝑖𝑖 𝑏𝑏𝑏𝑏𝑏𝑏1)

substituted the log(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟) with log(

wise FDR is 50% for the first bin, we get:

(𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏 𝐹𝐹𝐹𝐹𝐹𝐹 𝑖𝑖𝑖𝑖 𝑏𝑏𝑏𝑏𝑏𝑏1)

log(𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟) = log �

). For example, if the bin-

1 − (0.5)
�=0
(0.5)

Again, using a log odds ratio of 7 to ensure 99% probability of essentiality:
𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 log 𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜 = log(𝐵𝐵𝐵𝐵) + log(𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝 𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟)
7 = log(𝐵𝐵𝐵𝐵) + 0

Therefore, we assigned a binary call of essentiality to this gene in this cell line,
if BF>7, indicating that the probability of essentiality is ~99. Then we repeated the
process for all 8 screens, using the corresponding bin-wise FDR values from the
previous observations. Since the bin-wise FDR values are almost negligible for certain
bins as we have shown in the saturation modeling approach, we capped the prior log
ratio at 9 so that the BF threshold does not become too low while ensuring high
probability of essentiality. We repeated the sampling process 100 times, selecting 8
different screens in each iteration from every tissue type to minimize bias. For every
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tissue type, we recorded all binary calls for all genes in 100 iterations as well as the
cell lines that were sampled in each iteration. All of the analyses were performed using
Python version 3.6 using multiple packages including pandas (Reback et al., 2020),
NumPy (Harris et al., 2020), the sklearn.metrics, sklearn.utils, resample modules in
SciKits (Buitinck et al., 2013), Matplotlib (Hunter, 2007), seaborn (Waskom et al.,
2020), scipy.stats module in scipy (SciPy 1.0 Contributors et al., 2020)

3.5.3 Evaluation of essential protein complexes
Essential protein complexes were downloaded as they are defined in the
comprehensive resource of mammalian protein complex (CORUM) database (Giurgiu
et al., 2019). The Bayes factors of the genes in each complex was binarized using
BF>10 to identify non-essential members of each complex according to thresholding
using BAGEL to demonstrate the false negative problem in these essential
complexes.

3.5.4 Identification of false negative genes in tissues
Mean frequency observations out of 8 screens in adjusted priors approach
were compared to those from the saturation modeling approach described in section
2.3.3 for both the Avana and Sanger screens. The observations were binned from
each approach and genes that were placed in the eighth bin in the adjusted priors
approach excluding those that were already placed in the eighth bin in the saturation
modeling approach were defined as false negatives in a tissue type.
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3.5.5 Detecting subgroups of cell lines with adjusted priors
approach
For this analysis, we converted our tissue level mean frequency adjusted priors
calls to cell line level binary calls. For each gene in every cell line, we first calculated
the total number of binary calls made across 100 iterations and then we normalized
by the number of times each cell line was chosen across 100 iterations to get a mean
cell line level adjusted prior call. Prior to clustering, for each tissue type, we removed
genes with mean binary adjusted priors calls <0.2 and genes with mean binary
adjusted priors calls >0.8 across all cell lines from a particular tissue type in order to
capture genes with high variance of calls. We then performed hierarchical clustering
of the cell lines from each tissue type using the cell line level mean adjusted priors
calls using seaborn.clustermap function of the seaborn package with Euclidean
distances and ward metric.

3.6 Supplemental data
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Figure S3.1. Adjusted priors approach shows similar trends in the Sanger dataset. A)
Comparison of the frequency of essential gene hits in saturation modeling versus adjusted
priors approach in colorectal cancer cell lines Sanger dataset. B) Violin plots showing the
distribution of the essentiality scores (Bayes Factor, BFs) of the hits, in the screens where
they were not observed as essential using adjusted priors approach. C) Delta-shift in
frequency of observations out of 8 screens with adjusted priors approach (y-axis) compared
to saturation modeling approach (x-axis) for the colorectal cancer cell lines in the Sanger data.
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Chapter 4: Blind-spots in genome-wide CRISPRCas9 knockout screens
The work in this chapter has been adapted from the following publication:
Dede, Merve, Megan McLaughlin, Eiru Kim, and Traver Hart. "Multiplex
enCas12a screens detect functional buffering among paralogs otherwise masked in
monogenic Cas9 knockout screens." Genome biology 21, no. 1 (2020): 1-19.
Copyright permissions are not required. This is an open access article
distributed under the terms of the Creative Commons CC BY license:
https://creativecommons.org/licenses/by/4.0/.
So far, we have conducted an extensive analysis of genome-wide CRISPRCas9 knockout screens to accurately detect essential genes in human cancer cell
lines. We demonstrated all the useful information we can learn from these screens,
including the biases we observed and the false negatives we rescued. This chapter
will focus on what is missing from these datasets; the blind-spots in CRISPR screens.

4.1 Abstract
Major efforts on pooled library CRISPR knockout screening across hundreds
of cell lines have identified genes whose disruption leads to fitness defects, a critical
step in identifying candidate cancer targets. However, the number of essential genes
detected from these monogenic knockout screens are very low compared to the
number of constitutively expressed genes in a cell, raising the question of why there
are so few essential genes. Through a systematic analysis of screen data in cancer
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cell lines generated by the Cancer Dependency Map, we observed that half of all
constitutively-expressed genes are never hits in any CRISPR screen, and that these
never-essentials are highly enriched for paralogs. We investigated paralog buffering
through systematic dual-gene CRISPR knockout screening by testing algorithmically
defined ~400 candidate paralog pairs with the enCas12a multiplex knockout system
in three cell lines. We observed 24 synthetic lethal paralog pairs which have escaped
detection by monogenic knockout screens at stringent thresholds. Nineteen of 24
(79%) synthetic lethal interactions were present in at least two out of three cell lines
and 14 of 24 (58%) were present in all three cell lines tested, including alternate
subunits of stable protein complexes as well as functionally redundant enzymes.
Together these observations strongly suggest that paralogs represent a targetable set
of genetic dependencies that are systematically under-represented among cellessential genes due to genetic buffering in monogenic CRISPR-based mammalian
functional genomics approaches.

4.2 Introduction
The adaptation of CRISPR-Cas9 system to genome-wide knockout screens in
mammalian cells has greatly transformed the search for cancer specific genomic
vulnerabilities that can be targeted therapeutically. Monogenic pooled library CRISPRCas9 knockout screens revealed that mammalian cells have as much as 3-4 times
more essential genes than the previous RNAi technology was able to detect at the
same false discovery rate (Hart et al., 2014). Moreover through immense monogenic
screening efforts, multiple groups revealed lists of ~2000 highly concordant human
essential genes, and comparison of CRISPR technology to orthogonal techniques
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such as random insertion of gene traps also showed consistent results (Blomen et al.,
2015b; Hart et al., 2015; Wang et al., 2015).

However, even with the CRISPR technology, the number of essential genes
detected through these screens is still far less than the number of genes constitutively
expressed in a given cell line. This phenomenon was previously observed in
systematic gene knockout studies in S. cerevisiae (Giaever et al., 2002; Winzeler et
al., 1999), where only 17% of yeast genes were essential for growth in rich medium
(Winzeler et al., 1999). A closer look at the biological characteristics that define
essentiality revealed a modular nature of gene essentiality (Hart et al., 2007) in which
essentiality is not a characteristic of the protein or gene itself, but is rather defined by
the protein complex to which the protein belongs. While genes that encode for
members of a protein complex were shown to be more likely to be essential,
paralogous genes were less likely to be essential (Gu et al., 2003). However, a later
study showed that a binary classification of genes into essential and non-essential
was misleading due to the context-dependent nature of gene essentiality and that 97%
of yeast genes showed some growth phenotype under different environmental
conditions (Hillenmeyer et al., 2008). A similar study in C. elegans (Arun K. Ramani
et al., 2012) suggested that virtually every gene is required for optimal growth in some
condition.

Paralogous genes arise from gene duplication events, which is a mechanism
to create new genes. While gene duplication can result in two functionally distinct
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genes over time, more frequently, the genes preserve a proportion of functional
overlap through the process of subfunctionalization (Brookfield, 1997; Conant and
Wolfe, 2008). In yeast gene deletion studies, singletons, which are genes without
paralogs, were more than twice as likely as paralogous genes to be essential (Gu et
al., 2003), indicating the role of paralogs in genetic buffering and suggesting that that
paralogs can affect how the yeast cells can respond to genetic perturbations. The
buffering ability of paralogs to each other’s loss can be explained by their functional
redundancy. Double deletion studies of paralog gene pairs in yeast revealed that
synthetic lethality occurred with depletion of both paralog pairs, resulting in a fitness
defect that was more than the expected additive effect of individual gene depletions
(DeLuna et al., 2008). Further analyses determined sequence similarity of paralog
pairs as a predictive characteristic for the level of functional redundancy (Li et al.,
2010). A major open question remains whether these findings hold true for human
cells generally and cancer cells specifically.

Recent studies investigated paralog dependencies in monogenic genome-wide
CRISPR-Cas9 knockout screens in human cells, revealing differential effects of
paralogs on cellular fitness. One study showed that paralogs are less likely to be
essential in whole-genome CRISPR knockout fitness screens than singleton genes
(De Kegel and Ryan, 2019), while another study demonstrated that paralogs that form
heterodimers are more deleterious to the cell compared to non-heterodimer forming
paralogs (Dandage and Landry, 2019). However, these studies did not take into
account the effect of tissue-specific expression of the paralog pairs.
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In this study, using publicly available genome wide screen data of genetically
heterogeneous cell lines from the Cancer Dependency Map initiative (Meyers et al.,
2017; Tsherniak et al., 2017) we investigate paralogs among constitutively expressed
never-essential genes as a set of targetable genetic dependencies that are
systematically excluded in monogenic CRISPR-Cas9 knockout screening. We further
demonstrate experimentally, using CRISPR-enCas12a multiplex knockouts, that dualgene screens reveal synthetic lethality among targeted paralogs.

4.3 Results
4.3.1 Why do we have so few essential genes in genome-wide
CRISPR-Cas9 knockout screens?
The question of what is missing from the monogenic knockout screens was
based on an interesting observation we made during our analyses. Besides differential
gene essentiality, the relationship between gene essentiality and gene expression
patterns can also give important insights. Therefore, we first evaluated the gene
expression patterns across hundreds of cell lines from the Cancer Cell Line
Encyclopedia (CCLE) (Barretina et al., 2012). We took the mean and standard
deviation of gene expression across 684 cell lines with high-quality CRISPR screens
from the Avana 19Q4 data release (Broad DepMap, 2020c) and modeled the joint
distribution with a linear combination Gaussian mixture models to perform an unbiased
depiction of data. We ran the model with different numbers of components and
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determined that the model with three components recapitulated the actual data the
most accurately (Figure 4.1).
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Figure 4.1. Gaussian mixture modeling (GMM) of gene expression of Avana 19Q4 cell
lines. A) Scatter plot of standard deviation of expression versus mean expression of genes
assayed in Avana library in Avana19Q4 cell lines. B) Contour plots of the two Gaussians
from a two-component mixture model of data shown in A. C) Contour plots of threecomponent GMM. D) Contour plots of four-component GMM. Figure adapted from Dede,
M., McLaughlin, M., Kim, E., & Hart, T. (2020). Multiplex enCas12a screens detect
functional buffering among paralogs otherwise masked in monogenic Cas9 knockout
screens. Genome biology, 21(1), 1-19. Copyright permissions are not required. This article
is
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Using the three-component GMM, we observed that the three groups
corresponded to the three major populations in the data: constitutively expressed
genes (high expression, low variance), never-expressed genes (low expression, low
variance), and genes that show variable, sometimes tissue-specific gene expression
(“sometimes expressed” genes, high variance) (Figure 4.2A).

A

B

Figure 4.2. Many constitutively expressed genes are never-essential in monogenic knockout
screens. A) Scatter plot of mean versus standard deviation of log (TPM) gene expression in
CCLE. Genes are color coded by components of a 3- element 2-d Gaussian mixture model.
B) Fraction of context, common and never-essentials as a function of gene expression profiles.
Figure adapted from Dede, M., McLaughlin, M., Kim, E., & Hart, T. (2020). Multiplex enCas12a
screens detect functional buffering among paralogs otherwise masked in monogenic Cas9
knockout screens. Genome biology, 21(1), 1-19. Copyright permissions are not required. This
article

is

available

under
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Creative

https://creativecommons.org/licenses/by/4.0/.

Commons

International

License

–

126
Next, we evaluated the fraction of essential genes in each population.
Consistent with our previous analyses, we defined essential genes as those with
BAGEL-derived BF>10, which represents a high-confidence threshold corresponding
to a posterior probability of essentiality of ~99%. When we look at the distributions,
we can see that the majority of common essential genes that we defined in section
2.3.5 are constitutively expressed as we would expect, while the context-dependent
essential genes are divided across the constitutive expression and tissue-specific
expression. Interestingly, among constitutively expressed genes, many are never
essential in any CRISPR knockout fitness screen (3,032 of 7,282; 42%; Figure 4.2B).

These observations regarding the constitutively expressed genes raised the
question about why we observe so few essential genes in these genetically
heterogenous screens. Based on work in previous studied in yeast and nematodes
(Arun K. Ramani et al., 2012), we naively assumed that all constitutively expressed
genes should be essential in at least some context, and hypothesized that some
combination of environmental or genetic buffering masks the fitness consequences of
individual gene knockouts.

4.3.2 Knockout phenotypes of never-essential genes are being
buffered by their paralogs
A previous important study by De Kegel and Ryan observed that paralogs are
less likely to be essential in whole-genome CRISPR knockout fitness screens than
singletons (De Kegel and Ryan, 2019). This work discovered 226 cases where higher
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essentiality in one paralog was accompanied by lower gene expression in the other,
supporting the assertion that paralog buffering masks monogenic knockout fitness
effects. We sought to extend this observation to include constitutively expressed
genes. We obtained the list of the paralogs of human protein coding genes from
Ensembl Biomart (Zerbino et al., 2017) along with protein sequence similarity
information (see Methods). After filtering for constitutively expressed genes, we
observed that paralogs show a wide range of amino acid sequence similarity, with the
majority showing relatively low identity (Figure 4.3A). To evaluate whether paralogs
are enriched in constitutively expressed never-essentials (hereafter “neveressentials”), we adopted a sliding scale of sequence identity and measured, at each
threshold, the fraction of never-essentials and the fraction of common essentials
captured. As shown in Figure 4.3B, as sequence similarity stringency is relaxed,
never-essentials are more likely to have a paralog than common essentials. At 35%
or greater sequence similarity, nearly a third (27.9%) of constitutively expressed
never-essentials have a paralog, compared with only 11.6% of common essentials
(P<10-89, Z-test for difference in proportions; Figure 4.3B green circle).
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Figure 4.3. Never-essential genes are enriched in paralogs. A) Paralog pairwise amino-acid
sequence identity among constitutively expressed paralogs. Green lines indicate 35% sequence
similarity. B) Fraction of common essentials with a paralog versus the fraction of never-essentials
with a paralog, colored by paralog sequence similarity. Green circle indicates 35% sequence
similarity. Figure adapted from Dede, M., McLaughlin, M., Kim, E., & Hart, T. (2020). Multiplex
enCas12a screens detect functional buffering among paralogs otherwise masked in monogenic
Cas9 knockout screens. Genome biology, 21(1), 1-19. Copyright permissions are not required.
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4.3.3 Computational detection of synthetic lethal paralog pairs
The following work was done in collaboration with postdoctoral fellow lab
member Eiru Kim, Ph.D.
To identify functionally redundant paralogs, we explored the Avana and Sanger
data to find cases where loss of function of one member of a paralog pair resulted in
increased dependency on the other (Figure 4.4A). We limited the search for functional
redundancy to genes classified as constitutively expressed according to our model,
which excludes false associations arising from tissue-specific expression of paralog
family members. The search is further constrained by requiring that one member of
the pair show loss of function, either through predicted deleterious mutation or by
severe decrease in gene expression (see Methods), in a sufficient number of cell lines
to result in a statistically significant difference in gene essentiality of the other member.
By applying this test to 628 gene pairs in the Avana data and 432 gene pairs in Project
Score (Figure 4.4A), we detected a total of 66 such cases of putative functional
buffering at a P-value < 0.01, of which 32 (48%) are common between the two sets
(Figure 4.4B,C).
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Figure 4.4. Computational detection of constitutively-expressed paralog buffering. A)
Overview of computational methodology: loss of function in one member of a paralog pairs
gives rise to gene essentiality in the other member. The bar chart indicates the number of
pairs testable by this method. B) Summary of the results by the Broad dataset and Sanger
dataset. C) Overlap of computationally derived synthetic lethal hits between the Sanger
(Project Score) and Broad (DepMap/Avana) datasets. Figure made by Eiru Kim, Ph.D., used
with permission. Figure adapted from Dede, M., McLaughlin, M., Kim, E., & Hart, T. (2020).
Multiplex enCas12a screens detect functional buffering among paralogs otherwise masked in
monogenic Cas9 knockout screens. Genome biology, 21(1), 1-19. Copyright permissions are
not required. This article is available under a Creative Commons International License –
https://creativecommons.org/licenses/by/4.0/.

In our results, two well-described cases in the BAF (mammalian SWI/SNF) complex
were immediately apparent: mutations in SMARCA4 are strongly associated with
dependency on paralog SMARCA2 (P<10-10; Figure 4.5A), and mutations in ARID1A
are associated with ARID1B dependency (P<10-9; Figure 4.5B). Expanding loss-of-
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function to include significantly depleted gene expression also reveals an emergent
dependency on RPP25L when RPP25 is depleted (P<10-52; Figure 4.5C). The two
genes encode redundant subunits of RNAse P, a ribonuclease critical for maturation
of tRNA, whose functional buffering was previously observed (Wang et al., 2015). A
fourth example is FAM50A/FAM50B putative functional redundancy (Figure 4.5D).
Interestingly, virtually nothing is known about the biological role of these genes.
A

B

C

D
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Figure 4.5. Computationally detected synthetic lethal paralog pairs. A-D) Scatter. Plots of
Bayes Factors of paralog pairs, with labels indicating loss of function (LOF) and corresponding
p-values. Figure made by Eiru Kim, Ph.D., used with permission. Figure adapted from Dede,
M., McLaughlin, M., Kim, E., & Hart, T. (2020). Multiplex enCas12a screens detect functional
buffering among paralogs otherwise masked in monogenic Cas9 knockout screens. Genome
biology, 21(1), 1-19. Copyright permissions are not required. This article is available under a
Creative Commons International License – https://creativecommons.org/licenses/by/4.0/.

Unfortunately, with this analysis we were not able to identify a lot of synthetic lethal
paralog pairs, since the cell lines screened by CRISPR knockout libraries only contain
LOF alleles of a fraction of the candidate paralogs, limiting this discovery avenue to a
few dozen pairs. The aforementioned paralog study also identified computationally
identified paralog synthetic lethals. Therefore, we compared our hits with the hits in
De Kegel and Ryan study (De Kegel and Ryan, 2019), and showed that more than
half of our computationally derived hits (39 of 66, 59%;Figure 4.6) are present in their
study, indicating strong concordance between the two approaches. Nevertheless, we
observed a large number of hits unique to each approach, clearly indicating that
neither approach is saturating, and additional methods, both computational and
experimental, are required to discover the complete set of paralog synthetic lethal
interactions.
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Figure 4.6. Comparison of computationally derived hits from our analysis with hits in De Kegel
and Ryan et al study. Figure adapted from Dede, M., McLaughlin, M., Kim, E., & Hart, T.
(2020). Multiplex enCas12a screens detect functional buffering among paralogs otherwise
masked in monogenic Cas9 knockout screens. Genome biology, 21(1), 1-19. Copyright
permissions are not required. This article is available under a Creative Commons International
License – https://creativecommons.org/licenses/by/4.0/.

4.3.4 Discussion and conclusions
CRISPR technology has revolutionized mammalian functional genomics and cancer
targeting by leveraging endogenous DNA repair machinery to generate gene
knockouts on a genomic scale. Extensive screening of cancer cell lines has been
performed under the DepMap and Project Score initiatives to identify context-specific
weaknesses and cancer biomarkers. Analyses of this data have revealed activation
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of oncogenic pathways and oncogene dependencies (Tsherniak et al., 2017) as well
as biomarker type dependencies such as Werner helicase, WRN, in colorectal and
ovarian cell lines with MSI (Behan et al., 2019; Chan et al., 2019). However, despite
these efforts, questions about what might be systematically missing from these data
have, to our knowledge, not been rigorously explored.

We note that there are about 7,000 genes that are constitutively expressed in each
cell, but only about half of these are ever detected as essential. Studies in model
organisms suggest that virtually every gene shows a growth phenotype under some
environmental condition (Hillenmeyer et al., 2008; Arun K. Ramani et al., 2012). It is
unknown whether this holds true for individual mammalian cells, though tumors are
often modeled as though they are colonies of single-celled organisms. It is also the
case that most genetic screens of tumor cells are carried out under permissive growth
conditions, minimizing nutrient and oxidative stress to maximize growth rate and
improve detection of dropouts. Thus, the degree of environmental buffering is largely
unknown for these constitutively expressed never-essentials.

However, these never-essentials are highly enriched for paralogs. They are ~3 times
more likely to have a paralog than always-essentials, suggesting that functional
redundancy by related genes masks detection of a substantial population of genes in
monogenic CRISPR knockout screens. This has profound implications for efforts to
match targeted drugs with tumor genotypes, and to discover new candidate drug
targets. Targeted small molecules often don’t discriminate, or discriminate poorly,
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between closely related paralogs, and it is often their promiscuity rather than their
specificity that renders them effective. For example, MEK inhibitor trametinib
effectively targets the protein products of both MAP2K1 and MAP2K2, redundant
kinases downstream of RAS/RAF oncogenes, but the functional redundancy of these
genes renders them both invisible to monogenic CRISPR screens, even in RAS/RAF
backgrounds (Kim et al., 2019).

Recent developments in CRISPR screening technology enable effective genetic
targeting of multiple genes simultaneously. Cas12a, previously known as Cpf1, is able
to process a polycistronic mRNA to generate multiple CRISPR RNAs (crRNAs). This
makes multiplexing much easier compared to inefficient Cas9 based multiplex
systems which requires each guide RNA to be expressed by its own promoter. The
improved version of this enzyme, enCas12a (Kleinstiver et al., 2019), coupled with an
effective guide design algorithm (DeWeirdt et al., 2020) presents a powerful platform
for multiplex genetic perturbation. Multiplex guide libraries can be synthesized directly,
without requiring additional targeted or random mixing cloning steps, allowing direct
assay of specific gene pairs as described here with roughly the same level of effort as
a now-standard Cas9 monogenic screen. The robustness of predicted guide cutting
efficiency remains untested relative to Cas9, given the relatively small amount of
enCas12a data available, suggesting adopters of this technology should err toward
caution when deciding on parameters for new experiments (e.g. number of guides per
gene, number of gene-vs-control guide pairs). Nevertheless, as we demonstrate here,
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this platform holds enormous potential for exploring the stability and plasticity of
genetic interactions in human cells.

4.3.5 Dual gene CRISPR knockout screening with enCas12a and
identification of synthetic lethal paralog pairs
The following work was done in collaboration with experimental team member
Megan McLaughlin who performed the experimental work and Traver Hart, Ph.D .
Considering the limitations of our computational method to detect paralog
synthetic lethal pairs, we sought to expand our knowledge of paralog buffering through
systematic experimental dual-gene CRISPR knockout screening. We decided to
utilize the Cas12a enzyme, formerly known asCpf1, to conduct our experiments with
our CRISPR-Cas12a system which has some important differences compared to
Cas9. Cas9 requires a G-rich protospacer adjacent motif (PAM) sequence, while
Cas12a prefers a T-rich PAM (Zetsche et al., 2015). The two enzymes also differ in
location and type of cuts they make. Cas9 causes a double stranded break at the PAM
proximal end of the sgRNA with a blunt cut. However, Cas12a cuts at the PAM distal
end of the sgRNA with a staggered cut (Zetsche et al., 2015). Another key difference
is between the constant regions of these two enzymes. Cas9 has a 76 nucleotide
constant region called the tracrRNA while Cas12a has a 20 nucleotide constant region
which we refer to as the direct repeat. However, the most important reason for why
we are interested in Cas12a is that it enables multiplexing since it has an endogenous
RNA endonuclease function that enables processing and utilization of multiple gRNA
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from a single polycistronic transcript (Zetsche et al., 2015). This is in contrast to Cas9
based systems which require each sgRNA to be expressed by its own promoter
(Figure 4.7).

Cas12a
Figure 4.7. Cas12a requires only one promoter to drive expression of multiple guides in
contrast to Cas9 based systems.

Moreover, the modified version of this enzyme, enCas12a, offers superior
performance in genetic screens in mammalian cells (DeWeirdt et al., 2020; Kleinstiver
et al., 2019). A key advantage of this system is that specific guide pairs can be
synthesized in a single oligonucleotide, allowing one-step library design, which offers
a major advantage over multiplex Cas9 systems (Chen et al., 2015; Cong et al., 2013;
Kabadi et al., 2014; Shen et al., 2017). We therefore sought to apply the enCas12a
multiplex knockout system to systematically identify paralog synthetic lethals.

We first identified 400 candidate paralog pairs to test design a 12K library.
These gene pairs were algorithmically selected based on several criteria, including
amino acid sequence similarity, mRNA expression and co-expression, and whether
either gene is frequently essential in DepMap. We manually added five additional
candidate gene pairs from the literature: SMARCA2-SMARCA4, CHD1-CHD3, ME2-
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ME3, BCL2L1-MCL1, and BRCA1-PARP1, for a total of 405 targeted gene pairs. For
each gene, up to three CRISPR RNA (crRNA) were selected using guides designed
by DeWeirdt et al (DeWeirdt et al., 2020). Each gene pair was targeted with all 9
combinations of guides, in both A-B and B-A orientations, for a total of 18 clones
targeting each pair. To evaluate single-knockout phenotype, we paired gene-targeted
crRNA with three guides drawn from a pool of guides targeting 50 nonessential genes
(Figure 4.8A). We additionally targeted 50 essential genes, paired with random
nonessential guides, to serve as quality controls for the screens.
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Figure 4.8. Multiplex gene knockout with enCas12a. A) Experimental design. EnCas12a
crRNA dual-guide array design. Each construct targets two genes; each gene is targeted by 3
crRNA; each candidate paralog gene pair is targeted by 18 gene-gene constructs, with six
gene-control constructs per gene (including both A-B and B-A orientations. B) Quality control
plot showing the separation of SMF of constructs targeting control essential and nonessential
genes. Figure adapted from Dede, M., McLaughlin, M., Kim, E., & Hart, T. (2020). Multiplex
enCas12a screens detect functional buffering among paralogs otherwise masked in monogenic
Cas9 knockout screens. Genome biology, 21(1), 1-19. Copyright permissions are not required.
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We transduced the library into enCas12a-expressing cells from three cancer
cell lines of diverse origins: A549, a KRAS-driven lung cancer cell line; HT29, a BRAFmutant colorectal cancer cell line, and OVCAR8 ovarian cancer cells. Cells were
passaged in three replicates for 10 doublings and the relative abundance of each dual-

–
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guide construct was measured by 75-base single end sequencing of the target
amplicon, with fold changes measured relative to abundance in the plasmid pool.

Quality control steps including abundance and distribution of read counts,
clustering of raw read counts and fold changes, and separation of essential and
nonessential control genes indicated effective screen performance (Figure 4.8B).
Additionally, high correlation of A-B and B-A guide pairs (Figure 4.9A) indicate
negligible positional bias in the enCas12a guide arrays. We therefore included both
A-B and B-A pairs in all subsequent fitness calculations.
A

B
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Figure 4.9. enCas12a screen shows negligible position effects and displays correlation
between SMF and Bayes Factors. A) Scatter plot of all mirror constructs (same crRNA in A-B
and B-A orientations) showing lack of positional effects. B) SMF in A549 screen versus gene
BF in Avana data. Figure adapted from Dede, M., McLaughlin, M., Kim, E., & Hart, T. (2020).
Multiplex enCas12a screens detect functional buffering among paralogs otherwise masked in
monogenic Cas9 knockout screens. Genome biology, 21(1), 1-19. Copyright permissions are
not required. This article is available under a Creative Commons International License –
https://creativecommons.org/licenses/by/4.0/.

To calculate genetic interaction/synthetic lethality, we measured the single
mutant fitness (SMF) for each gene as the mean fold change of the gene-control
constructs. For control essential genes, SMF in our enCas12a screen correlates with
BAGEL-derived Bayes Factor scores for the DepMap screens in the same cell lines
(Figure 4.9B). We then calculated the observed double mutant fitness (DMF) as the
mean log fold change of the dual-gene knockout constructs (18 constructs per gene
pair), and compared it to the expected DMF, the sum (in log space) of each gene’s
SMF to obtain delta log fold changes (dLFCs) (Figure 4.10A). To be able to make
comparisons across screens, we converted these dLFCs to z-delta log fold changes
(zdLFC), by truncating the top and bottom 2.5% of dLFC scores. As has been widely
observed in genetic interaction screens, most digenic knockouts do not result in an
unexpected phenotype; here we observe that the distribution of zdLFC values has
most of its mass around zero (no synthetic effect), with a long tail of negative (synthetic
sick/lethal) zdLFC scores (Figure 4.10B).
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Figure 4.10. Synthetic lethality and distribution of zdLFCs in paralog screen. A) Evaluating
synthetic lethality. Single mutant fitness (SMF) is the mean log fold change of control guides
targeting a single gene. Expected double mutant fitness (DMF) is the sum of SMFs. Observed
DMF is the mean log fold change of dual-targeting constructs. Delta log fold change (dLFC) is
the difference between observed and expected log fold change. B) The distribution of ztransformed dLFCs of paralog pairs in the three cell lines tested.Figure adapted from Dede,
M., McLaughlin, M., Kim, E., & Hart, T. (2020). Multiplex enCas12a screens detect functional
buffering among paralogs otherwise masked in monogenic Cas9 knockout screens. Genome
biology, 21(1), 1-19. Copyright permissions are not required. This article is available under a
Creative Commons International License – https://creativecommons.org/licenses/by/4.0/.
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At a zdLFC score < -3, all three screens showed high concordance, with 19 of
24 (79%) synthetic lethals present in at least two out of three cell lines and 14 of 24
(58%) present in all three (Figure 4.11A,B). We utilized the OHNOLOGS v2.0
database, which is a repository of genes arising from whole genome duplications
(Singh et al., 2015) to evaluate if there is an enrichment among ohnologs. We
observed that fifteen of the 24 hits (62.5%) are ohnologs, gene copies resulting from
whole-genome duplication (Singh et al., 2015), compared to 246 of the 405 gene pairs
tested in our study (60.7%), indicating neither enrichment nor depletion of synthetic
lethals

among

ohnologs

(P=0.86,
B

A

Z-test

for

difference

of

proportions).
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Figure 4.11. Synthetic lethal paralog pairs. A) Overlap of 24 synthetic lethal paralog hits
with zdLFC < -3 in any of the three cell lines. B) Heatmap showing the zdLFC scores for the
24 hits in the three cell lines. Figure adapted from Dede, M., McLaughlin, M., Kim, E., &
Hart, T. (2020). Multiplex enCas12a screens detect functional buffering among paralogs
otherwise masked in monogenic Cas9 knockout screens. Genome biology, 21(1), 1-19.
Copyright permissions are not required. This article is available under a Creative Commons
International License – https://creativecommons.org/licenses/by/4.0/.

A previous study indicated that simple difference in log fold change is not an
effective measure of evaluating genetic interactions and the authors offered a more
detailed approach to calculate such interactions . Therefore we evaluated the
concordance of our zdLFC scores with the GEMINI scores and found that our zdLFCs
are highly correlated with GEMINI (Zamanighomi et al., 2019), with R2 values ranging
from 0.59 (A549) to 0.74 (OVCAR8), and the two methods offer essentially no
difference in hit calls (Figure 4.12).
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Figure 4.12. Comparison of zdLFC scores to scores generated by GEMINI. A) zdLFC vs
GEMINI scores for 24 synthetic lethal pairs with their respective correlation coefficients. B)
zdLFC vs GEMINI scores for all tested paralog pairs with their respective correlation
coefficients. Figure adapted from Dede, M., McLaughlin, M., Kim, E., & Hart, T. (2020).
Multiplex enCas12a screens detect functional buffering among paralogs otherwise masked in
monogenic Cas9 knockout screens. Genome biology, 21(1), 1-19. Copyright permissions are
not required. This article is available under a Creative Commons International License –
https://creativecommons.org/licenses/by/4.0/.
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A closer look at the many top-scoring hits indicates strong concordance with
other data corroborating a functional buffering/synthetic lethal relationship. RNA
helicases DDX19A and DDX19B show characteristics of synthetic lethality as
described by De Kegel and Ryan (De Kegel and Ryan, 2019) across DepMap cell
lines, DDX19A is strongly essential only when DDX19B is expressed at low levels
(Figure 4.13).

Figure 4.13. DDX19A gene essentiality (BF) vs. DDX19B gene expression (logTPM) in Avana
data. Figure adapted from Dede, M., McLaughlin, M., Kim, E., & Hart, T. (2020). Multiplex
enCas12a screens detect functional buffering among paralogs otherwise masked in
monogenic Cas9 knockout screens. Genome biology, 21(1), 1-19. Copyright permissions are
not required. This article is available under a Creative Commons International License –
https://creativecommons.org/licenses/by/4.0/.

Similarly, TIAL1 low expression is associated with TIA1 increased essentiality Figure
4.11B. HDAC1/HDAC2 and MAPK1/MAPK3 paralog pairs also displayed strong
synthetic lethality across the cell lines we tested (Figure 4.11B). Genes CNOT7 and
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CNOT8 encode alternate subunits of the CCR4-NOT complex, a critical regulator of
eukaryotic gene expression (Lau et al., 2009). Other subunits are sporadically
essential in our three cell lines (Figure 4.14A) but frequently essential across DepMap
data, consistent with a constitutively essential protein complex. Moreover, CNOT7
essentiality is weakly but significantly anticorrelated with CNOT8 mRNA expression
(Pearson correlation coefficient -0.21, P<10-6). Likewise, COPS7A and COPS7B
encode alternate, replaceable subunits of the COP9 signalosome complex; other
subunits are irreplaceable and are uniformly essential in these cell lines Figure
4.14B).
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Figure 4.14. Selected co-complex interactions of synthetic lethal paralog pairs. A)
CNOT complex showing the synthetic lethality of the CNOT7/CNOT8 paralog pair,
with other members sporadically essential in the three cell lines tested. B) Members of
the essential COP9 signalosome complex show uniform essentiality across the tested
cell lines except the COPS7A/COPS7B which displays paralog synthetic lethality.

C)

CCNE1/CCNE2 shows synthetic lethality especially in OVCAR8 cells, where their cognate
cyclin dependent kinase CDK2 shows strong essentiality. D) Similar to C, CCNT1/CCNT2
are synthetic lethal where CDK9 is essential. Figure adapted from Dede, M., McLaughlin,
M., Kim, E., & Hart, T. (2020). Multiplex enCas12a screens detect functional buffering
among paralogs otherwise masked in monogenic Cas9 knockout screens. Genome
biology, 21(1), 1-19. Copyright permissions are not required. This article is available under
a Creative Commons International License – https://creativecommons.org/licenses/by/4.0/.

Strikingly, we observed that synthetic lethality, even among paralogs, can also
be context-dependent. Cyclin paralogs are often redundant interaction partners with
their cognate cyclin-dependent kinases; here, CCNE1 and CCNE2 are synthetic lethal
where CDK2 is highly essential, especially in OVCAR8 cells (Figure 4.14C). Similarly,
CCNT1-CCNT2 show weaker but significant synthetic lethality (zdLFC < -2.5 in A549
and < -1 in the other two cell lines) while their binding partner, CDK9, is highly essential
in all three (Figure 4.14D).

Though the synthetic lethal relationships between SWI/SNF complex members
ARID1A/ARID1B and SMARCA2/SMARCA4 are well described in the literature and
are detected in large scale screening data, their synthetic lethality only occurs where
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the SWI/SNF complex is itself essential. We test four paralog pairs in the BAF
complex: ARID1A/ARID1B, SMARCA2/SMARCA4, SMARCC1/SMARCC2, and
SMARCD1/SMARCD2, but we detect no synthetic lethal interactions, most likely
because the complex itself is not essential in the cell lines we tested.

Synthetic lethality between our hits is corroborated by a dual-gene knockout
screen using the CHyMErA hybrid Cas12/Cas9 system (Gonatopoulos-Pournatzis et
al., 2020). The 678 paralog pairs evaluated in the CHyMErA screens contain 110 pairs
targeted in our library, including 12 of the 24 hits we defined. Our results are generally
consistent, with TIA1/TIAL1, SAR1A/SAR1B, PITNA/PITNB, and CNOT7/CNOT8
scoring strongly in both assays Figure 4.15A-B). In contrast, MAPK1/MAPK3 and
CCNE1/CCNE2 are only hits in our cell lines. As with gene essentiality, synthetic
lethality is often highly context-dependent.
A

B
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Figure 4.15. Comparison of common paralog pairs tested in our enCas12a screen with
the hybrid Cas9/Cas12a CHyMErA screens. A) Comparison of the 12 enCas12a hits in
this study that were screened in HAP1 in cell line in the CHymErA study. B) Comparison
of all 110 paralog pairs tested in both enCas12a screen and the HAP1 CHymErA screen.
Figure adapted from Dede, M., McLaughlin, M., Kim, E., & Hart, T. (2020). Multiplex
enCas12a screens detect functional buffering among paralogs otherwise masked in
monogenic Cas9 knockout screens. Genome biology, 21(1), 1-19. Copyright permissions
are not required. This
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4.4 Discussion and conclusions
CRISPR technology has revolutionized mammalian functional genomics and
cancer targeting by leveraging endogenous DNA repair machinery to generate gene
knockouts on a genomic scale. Extensive screening of cancer cell lines has been
performed under the DepMap and Project Score initiatives to identify context-specific
weaknesses and cancer biomarkers. Analyses of this data have revealed activation
of oncogenic pathways and oncogene dependencies (Tsherniak et al., 2017) as well
as biomarker type dependencies such as Werner helicase, WRN, in colorectal and
ovarian cell lines with MSI (Behan et al., 2019; Chan et al., 2019). However, despite
these efforts, questions about what might be systematically missing from these data
have, to our knowledge, not been rigorously explored.
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We note that there are about 7,000 genes that are constitutively expressed in
each cell, but only about half of these are ever detected as essential. Studies in model
organisms suggest that virtually every gene shows a growth phenotype under some
environmental condition (Hillenmeyer et al., 2008; Arun K. Ramani et al., 2012). It is
unknown whether this holds true for individual mammalian cells, though tumors are
often modeled as though they are colonies of single-celled organisms. It is also the
case that most genetic screens of tumor cells are carried out under permissive growth
conditions, minimizing nutrient and oxidative stress to maximize growth rate and
improve detection of dropouts. Thus, the degree of environmental buffering is largely
unknown for these constitutively expressed never-essentials.

However, these never-essentials are highly enriched for paralogs. They are ~3
times more likely to have a paralog than always-essentials, suggesting that functional
redundancy by related genes masks detection of a substantial population of genes in
monogenic CRISPR knockout screens. This has profound implications for efforts to
match targeted drugs with tumor genotypes, and to discover new candidate drug
targets. Targeted small molecules often don’t discriminate, or discriminate poorly,
between closely related paralogs, and it is often their promiscuity rather than their
specificity that renders them effective. For example, MEK inhibitor trametinib
effectively targets the protein products of both MAP2K1 and MAP2K2, redundant
kinases downstream of RAS/RAF oncogenes, but the functional redundancy of these
genes renders them both invisible to monogenic CRISPR screens, even in RAS/RAF
backgrounds (Kim et al., 2019).
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Recent developments in CRISPR screening technology enable effective
genetic targeting of multiple genes simultaneously. Cas12a, previously known as
Cpf1, is able to process a polycistronic mRNA to generate multiple CRISPR RNAs
(crRNAs). This makes multiplexing much easier compared to inefficient Cas9 based
multiplex systems which requires each guide RNA to be expressed by its own
promoter. The improved version of this enzyme, enCas12a (Kleinstiver et al., 2019),
coupled with an effective guide design algorithm (DeWeirdt et al., 2020) presents a
powerful platform for multiplex genetic perturbation. Multiplex guide libraries can be
synthesized directly, without requiring additional targeted or random mixing cloning
steps, allowing direct assay of specific gene pairs as described here with roughly the
same level of effort as a now-standard Cas9 monogenic screen. The robustness of
predicted guide cutting efficiency remains untested relative to Cas9, given the
relatively small amount of enCas12a data available, suggesting adopters of this
technology should err toward caution when deciding on parameters for new
experiments (e.g. number of guides per gene, number of gene-vs-control guide pairs).
Nevertheless, as we demonstrate here, this platform holds enormous potential for
exploring the stability and plasticity of genetic interactions in human cells.

4.5 Methods
4.5.1 Pre-processing of DepMap essentiality data

154
A raw read count file of CRISPR pooled library screens for 690 cell lines using
Avana library (Meyers et al., 2017) (Broad DepMap project 19Q4) was downloaded
from the data depository (https://depmap.org/portal/). Also, we downloaded Project
Score (Sanger) screen (Behan et al., 2019) raw read counts for 323 cancer cells from
the data depository (https://score.depmap.sanger.ac.uk/). We filtered the dataset to
keep only the protein-coding genes for further analysis and updated their names using
HGNC (DeLuna et al., 2008) and CCDS (Farrell et al., 2014) database. We discarded
sgRNAs targeting multiple genes in Avana library to avoid genetic interaction effects.
The raw read counts were processed with the CRISPRcleanR (Iorio et al., 2018)
algorithm to correct for gene-independent fitness effects and calculate fold change.
After that, the CRISPRcleanR processed fold changes of each cell line were analyzed
through updated BAGEL2 build 114 (https://github.com/hart-lab/bagel). In comparison
with published BAGEL version v0.92 (Hart and Moffat, 2016), the updated version
employed a linear regression model to interpolate outliers and 10-fold cross validation
for data sampling. Essentiality of genes was measured as Bayes Factor (BF) based
on gold standard reference sets of 681 core essential genes and 927 nonessential
genes (Hart et al., 2017, 2014). Positive BF indicates essential genes and negative
BF indicates non-essential genes. Lists of core essential genes and nonessential
genes used in this study have been uploaded on the same repository with BAGEL2
software. To correct unexpected essentiality by sgRNAs targeting non-protein coding
regions in addition to desired target protein coding gene, the multi-targeting effect of
sgRNAs has been corrected using BAGEL2 -m option. The screen quality was
evaluated by using “precision-recall” function in BAGEL2 software, and F-measure,
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the harmonic mean of precision and recall, was calculated for each screen at BF=5.
Finally, 581 cell lines for Broad screen and 320 cells for Sanger screen were selected
for further study by F-measure threshold 0.8 to prevent noise from marginal quality of
screens.

4.5.2 Defining constitutively expressed genes with Gaussian
Mixture Models
We utilized the log2 transformed RNA-seq TPM expression data from DepMap
Data Portal expression data for Avana19Q4 release for 684 cell lines (Meyers et al.,
2017; Tsherniak et al., 2017). The standard deviation of expression versus the mean
expression values for all genes assayed in the Avana library (N=17,755) across all
cell lines, for which the expression data was available, were plotted. Python 3.6.9
package sklearn and its GaussianMixture function was used to classify genes by
Gaussian mixture modeling based on mean and standard deviation of mRNA
expression. A three-component model was selected as the best fit to the data (Figure
4.1) since the addition of a fourth component resulted in two highly overlapping

component distributions. The group with the least expression and low standard
deviation was labeled as never expressed, the second group with very high standard
deviation and a range of mean expression values was labelled as sometimes
expressed and the constitutively expressed group with high mean expression and low
standard deviation was classified as constitutively expressed genes. With this
classification, we identified 7,282 always expressed, 4,544 never expressed and
5,929 sometimes expressed genes in the Avana dataset.
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4.5.3 Identification of the set of paralogs to be tested

To identify and predict paralog pairs which we hypothesized to be enriched in
synthetic lethal interactions, we obtained the paralogs of all human protein coding
genes from Ensembl Biomart (Zerbino et al., 2017). Next, we applied multiple filters
on various features of these paralog pairs including percent sequence similarity, mean
expression, standard deviation of expression, co-expression and gene essentiality
profiles across all cell lines. We then built a network of paralogous gene families using
Cytoscape (Shannon, 2003) and filtered them initially for protein sequence similarity
greater than or equal to 45%, mean expression (logTPM) >1.5, standard deviation of
expression <1.25, co-expression Pearson correlation coefficient >0.1. Finally, we
removed genes that were essential in more than 30 cell lines in order to eliminate
essential pairs, resulting in a set of 400 pairs. In addition, we manually added several
candidate synthetic lethals from previous literature, including SMARCA2/SMARCA4,
CDH1/CHD3, ME2/ME3, BCL2L1/MCL1, and BRCA1/PARP1 to get a total of 405
pairs in our study`.

4.5.4 Computational discovery of functional redundancy between
paralogs in DepMap and Sanger Screens
To investigate evidence for the functional redundancy between paralogous
genes in Broad and Sanger screens, we tested whether a gene is essential when its
paralog partner exhibits a loss of function phenotype. Firstly, we defined loss of
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function (LOF) as either the presence of a damaging mutation calls (we considered
both frameshift or nonsense mutations) adopted from CCLE mutation data (Ghandi et
al., 2019) or depletion of expression (mean log TPM < 1.0, CCLE RNA-seq) or
presence of deletion (copy number < 0.1, CCLE Copy number data). Next, we
conducted a statistical test of synthetic essentiality which is defined when a gene is
observed as essential when its paralog partner loses its function. We filtered all protein
coding paralog pairs to obtain only one to one paralog pairs with at least 30%
sequence similarity for our analysis in order to maximize the number of paralog pairs
to conduct our statistical tests. Furthermore, we only considered pairs which have at
least two LOF calls and are essential in at least two cell lines. P-value was calculated
by the one-sided Fisher’s exact test on the 2x2 contingency table of the number of
cells classified by LOF and essential (BF > 10), and false discovery rate (FDR) was
calculated by the method of Benjamini & Hochberg. We addressed pairs bidirectional
ways, which test a significance of essentiality of gene A upon LOF of gene B and vice
versa. A total of 58 pairs among 628 tested pairs in the Broad dataset and 40 pairs
among 432 tested pairs in the Sanger dataset passed a threshold of P-value < 0.01.
Thirty-two pairs were common to both datasets.

4.5.5 Library design for enCas12a screen
We selected Cas12a CRISPR RNA sequences from a library from (DeWeirdt
et al., 2020). Guides were selected from an AsCas12a library design from July 2019,
representing an intermediate phase of development of the DeWeirdt et al work. Up to
the top three guide sequences were selected from the library for each of the 793
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candidate paralog genes (405 gene pairs), but given the restrictive TTTV PAM
sequence for AsCas12a, three guides were not available for every gene. For two
genes (ABHD16B, DGCR6), no crRNA were present in the library; pairs including
these genes were removed in the downstream analysis. As controls, a set of 50
nonessential and 50 pan-essential genes were chosen; genes were filtered for those
with 1:1 orthologs in both rat and mouse to provide a useful multi-species reference
set. These control genes are listed in Additional file 5: Table S4 of our published
manuscript (Dede et al., 2020a).

To design the library, we first pooled all crRNA targeting nonessential control
genes (141 crRNA targeting 50 genes). Then, for each paralog gene pair, we collected
all crRNA pairs in both orientations – for n=3 crRNA per gene, there are n2= 9 crRNA
pairs, or 18 total clones (A-B and B-A orientations for each). To generate singleknockout controls, we then took each crRNA targeting one of the paralogs and paired
it with a crRNA randomly drawn from the nonessential pool, again designing clones in
both A-B and B-A orientations, for a total of six control constructs per experimental
gene (where n=3 crRNA/gene). Finally, we took our set of control essential genes
(n=149 crRNA targeting 50 genes) and randomly paired each guide with a
nonessential guide, in both orientations, as described above, for a total of 298 positive
control guide constructs. The final library targets 841 genes (889 including
nonessential genes) and 403 specified gene pairs with 12,328 constructs.
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4.5.6 Screen analysis
Construct sequences were combined into FASTA format (“paralog_2mer.fa”)
and indexed with bowtie-build, and sequencing reads were mapped to this database
with bowtie (Langmead et al., 2009) with the following command line parameters (trim
ten 3’ bases, allow 3 mismatches, discard sequences which map to more than one
reference sequence):
bowtie

--trim3

10

-v

3

-m

1

-S

--sam-nohead

paralog_2mer

[fastq_files] > [output.sam]

Sequence mapping rates ranged from 37-58%, averaging ~47%. Using this
strict single-read mapping approach guarantees that only high-quality guide
constructs were evaluated. Read counts were combined into a single matrix for further
analysis.
Subsequent analysis was executed in Python notebooks, all of which are available at
https://figshare.com/articles/software/enCas12a_screen_analysis_pipeline/1227564
2 (Dede et al., 2020b). Mean read depth for all samples exceeded 500 reads/guide,
and all samples showed read distributions with minimal skew. A pseudocount of 5
reads was added to each construct in each sample, then read counts per sample were
normalized to an average of 500 reads/guide (6.2M reads/sample), and log fold
change for each guide was calculated relative to the plasmid sequence counts
(notebook cas12a-step01-screen_QC). Screen replicate quality was verified by
plotting the kernel density estimate of the fold changes of all control essential
constructs vs. all other constructs (see notebook cas12a-step04_calc_SMF). Screenlevel fold change for each construct was then calculated as the mean of replicate fold
changes.
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Single mutant/knockout fitness, SMF, for each gene was calculated as the
mean construct fold change of gene-control constructs, for both A and B position.
Construct-level consistency is shown in Figure 4.9A but gene level SMF is even more
consistent (see notebook cas12a-step04_calc_SMF), with Pearson correlation
coefficients ranging from 0.87 to 0.94. A-B and B-A constructs were subsequently
averaged to calculate sample-level SMF for each gene. The distribution of each shows
a left skew consistent with the dropout (negative SMF) of a proportion of the genes in
the sample.

Cell line
A549
HT29
OVCAR8

Mean SMF
-0.10
-0.10
-0.10

Median SMF
0.014
0.053
0.082

Table 2. Mean and Median SMF in three screens. Table adapted from Dede, M., McLaughlin,
M., Kim, E., & Hart, T. (2020). Multiplex enCas12a screens detect functional buffering among
paralogs otherwise masked in monogenic Cas9 knockout screens. Genome biology, 21(1), 119. Copyright permissions are not required. This article is available under a Creative
Commons International License – https://creativecommons.org/licenses/by/4.0/.

Difference in log fold change for a gene pair (dLFC) was calculated as observation,
the mean LFC of all constructs targeting the gene pair, minus expectation, the sum of
the SMF for the two genes. Given the skew of the SMF distributions, gene pairs with
small positive SMF values sum yield an expectation of a positive LFC and, therefore,
negative dLFC scores when the observed LFC is near zero. This explains the slight

161
negative offset of dLFC distributions and necessitates normalization before calling
hits. We normalized by Z-transformation after removing the top and bottom 2.5% of
scores (see notebook cas12a-step07_robustZ_of_dLFC). The resulting zdLFC table
was used for all subsequent analysis of synthetic lethality.
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Chapter 5: General discussion and final remarks
“A man cannot become a competent surgeon without the full knowledge of
human anatomy and physiology, and the physician without physiology and
chemistry flounders along in an aimless fashion, never able to gain any
accurate conception of disease, practicing a sort of popgun pharmacy, hitting
now the malady and again the patient, he himself not knowing which.”
Sir William Osler (1849–1919)
During my years as a medical student and as a physician, I have taken Sir
William Osler’s above quote to heart while seeing patients.

I was trained to

understand that the basis of medicine relies upon understanding the mechanisms
behind how the disease operates and affects the physiology of the patient. If we think
about the human body as a big system, when something goes wrong in the body whether it is due to an outside stimulus such as a bacterial infection or something
sporadic like a mutation- it triggers a series of reactions by which the body responds
through symptoms. As clinicians, we observe these signs carefully and using our
knowledge on the normal human body structure and function, we try to identify the
best treatment. Unfortunately, I experienced that the traditional approach to treating
cancer has been an example of the “popgun pharmacy” that Sir Osler mentions. The
treatment regimen for cancer usually involves a series of aimless combination of drugs
and invasive procedures without an understanding of the entire human body as an
inter-connected network of systems. Giving toxic doses of radiation to kill cancer cells,
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knowing very well that the procedure itself is harmful to the body is an example of the
desperate actions the clinicians have chosen to take. These approaches are in
complete contrast to how we are trained to “treat the patient and not the disease”.

Fortunately, with the developments in systems biology and functional
genomics, we do not have to adhere to these repeatedly failing “treatment”
methodologies where we only address the symptoms. Now, we have an opportunity
to go back to the basics and understand the molecular basis of cancer which will help
us view this disease as a systemic disorder. Beginning with understanding the
structure and function of genes, the interaction networks of gene products, hierarchical
organization of networks in a cell, then expanding our knowledge to the networks of
cells, and to organ systems is the key towards unravelling how cancer dysregulates
and rewires individual components in our body, creating systemic effects. The
complete sequencing of the human genome paved the way towards this goal,
demonstrating the need to identify the function of every gene in the human genome.
With advances in next generation sequencing, projects such as The Cancer Genome
Atlas (TCGA) enabled the molecular profiling of tumor samples from thousands or
cancer patients. These efforts yielded a previously unimaginable amount of data as
well as targeted cancer therapeutics with minimal side effects. However, although
genomic characterization helped us identify cancer specific mutations and genomic
expression profiles, the functional significance of these abnormalities have been
challenging to decipher only from genomic data. The net result is that only a fraction
of cancer patients can benefit from the perks of precision medicine since we are still
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a long way from analyzing every individual patients’ tumor for unique vulnerabilities
and predicting which drug would have the most favorable outcome.

Recent developments in functional genomics and high throughput CRISPR
technologies have enabled genome-scale perturbations to measure and quantify
cause and effect relationships. These efforts are crucial for studying gene function as
well as for determining cellular dependencies. Using data from genome-wide CRISPR
knockout screens, we can identify tumor-specific essential genes which represent
potential therapeutic targets. With large scale projects such as the Cancer
Dependency Map initiatives by the Broad and Sanger Institutes (Behan et al., 2019;
Tsherniak et al., 2017), we have extensive data to systematically investigate cancer
specific vulnerabilities.

In this dissertation, I described my efforts to advance our understanding of
essential genes in human cancer cell lines. I conducted a series of systematic
analyses in order to investigate what we can detect and what we are missing from
genome-wide CRISPR screens; demonstrating both the biases and blind-spots. In
Chapter 2, I described the synthetic genome modeling approach that addresses the
basic question of how many essential genes we expect to detect and what the error
rate is in an average monogenic knockout screen. This analysis is especially important
for establishing the expectations and limitations of the results from a typical screen. In
contrast to big projects such as the DepMap or Project Score, we and many other labs
do not typically screen hundreds of cell lines / replicates for an individual experiment.
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Instead, we perform the screens with a limited number of replicates and therefore it is
crucial to establish a baseline rate for these screens while interpreting the results.
Fortunately, the synthetic genome model resulted in a similar trend in both the Avana
and Sanger datasets, indicating that our method is not biased towards the library used
to screen the cell lines. In the same chapter, I also introduced our saturation modeling
approach which can identify high confidence essential genes in a given tissue type
using data from the DepMap data. As a continuation of the synthetic genome model
which gives us the expected number of essentials and the error rate in a screen, the
saturation model separates the actual essential genes from the false positives. With
this method, I updated our daisy model of essentiality with a new set of core essential
genes that are expected to be essential across all contexts. This extensive set of core
essential genes captures additional genes responsible for indispensable processes of
the cell, therefore it can serve as a better yardstick to evaluate screen qualities and
as a new gold standard set for the BAGEL algorithm. Surprisingly, the context
essential genes in different tissue types highly overlap and that tissue specific context
essentials are actually very rare. Regardless, these uniquely context specific
essentials include many tissue specific transcription factors which define pathways of
tissue specific differentiation. Another important observation from these analyses is
that there is a bias towards moderately expressed genes and that each screen comes
with a ~20% false negative rate, which represents an unknown set of essential genes
that we are failing to detect in these screens.
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In Chapter 3, I addressed this false negative problem described in the previous
chapter by developing the adjusted priors method that uses the information generated
from the saturation modeling approach to rescue the false negatives in the data. With
this approach, a substantial number of false negatives are rescued in both the Avana
and Sanger datasets, which increases the concordance of hits between the two
approaches. Moreover, adjusted priors can also be used to detect subtypes of cancer
cell lines which display differential essentiality for groups of genes that show functional
coherence.

After discussing all the information we are able to detect from CRISPR screens,
Chapter 4 reveals a major source for a blind-spot in these monogenic knockout
screens. While searching for an answer to why we detect so few essential genes in
these screens, I observed that almost half of all constitutively expressed genes are
not observed as essential in any monogenic knockout screen. Furthermore, these
never essentials are much more likely than common essentials to have paralogs which
indicates that their phenotypes are being masked due to functional buffering. We
tested this idea with the enCas12a system to perform dual knockouts of candidate
paralog pairs to identify multiple synthetic lethal interactions, indicating that multiplex
perturbations can reveal cancer specific dependencies that are invisible in monogenic
knockout screening efforts.

Collectively, in this thesis, I demonstrated the biases and blind-spots that were
spotted during our efforts to identify cancer-specific vulnerabilities from monogenic
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CRISPR-Cas9 knockout screens in heterogeneous sets of human cancer cell lines.
While the monogenic CRISPR screens have been extensively used to elucidate gene
function and to identify tumor specific weaknesses for potential therapeutic targeting,
they are insufficient to detect all genomic vulnerabilities in cancer cell lines. An
important gap we observed is that the single gene knockout screens are unable to
identify all cancer-specific genomic dependencies due to functional redundancy of the
paralog pairs. Although our work serves as a proof of concept for the capabilities of
enCas12a technology to achieve dual gene knockouts and identify paralog
dependencies based on double gene knockouts, future experiments are needed to
discover the complete catalog of paralog synthetic lethality. These experiments can
focus on testing more paralog pairs and in different genetic backgrounds since as we
have shown, synthetic lethality can also be context dependent. With these efforts,
more data will be generated to study features which can be used to predict paralog
synthetic lethality. We have evaluated features such as sequence similarity, coexpression, co-essentiality, etc. to develop a logistic regression model to predict which
paralogs are more likely to be synthetic lethal (not discussed in this thesis). However
these models were limited due to the rarity of the synthetic lethal paralog pairs,
creating a class imbalance problem as well as due to lack of extensive training set
data. Testing of more comprehensive set of paralog synthetic lethal relationships in
different genetic backgrounds can address these problems towards the development
of a predictive model of paralog synthetic lethality.
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Another limitation of our work is that we focused on only one to one paralogous
relationships with our dual enCas12a system but there are hundreds of paralog gene
families with more than two members. Fortunately, enCas12a system can be used to
efficiently generate simultaneous knockouts of multiple gene combinations instead of
just double knockouts to address these research questions.

Besides testing hypotheses related to paralog synthetic lethality, enCas12a
system can be utilized to identify a more comprehensive set of genetic interactions
and synthetic lethality across all genes in tumors. As I discussed above, human body
can be conceived as a big system of systems and therefore diseases like cancer
dysregulate and rewire the usual hierarchical organization of these systems.
enCas12a platform can be utilized to study multiplex genetic perturbations as it
happens in cancer, in order to identify emergent vulnerabilities when the pathways are
rewired. In addition to studying gene to gene interactions, enCas12a system can also
be used to create a multiplex perturbation platform to screen and model drug response
in patient tumor cells. Our observations in monogenic Cas9 knockout screens have
shown that these screens are unable to predict drug response when a cancer drug
targets a paralog gene family. By designing reagents that phenocopy drug activity with
enCas12a system, we can conduct screens in parallel with the drug treatment in order
to evaluate drug response to specific tumors. This idea can be applied to actual
patients’ tumors through in vivo screens which can advance precision medicine,
bringing us a step closer to identifying the unique vulnerabilities in a personalized
manner, matching the right patients with the right drugs.
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Finally, it is evident that capturing the complexity of the human cell and its
interactions with its environment is highly dependent on our technological ability to
model the system and detect the cellular adaptations to perturbations. Although
monogenic Cas9 knockout screens or dual enCas12a screens can offer important
insights into tumor specific gene essentiality, further technological advancements are
needed to develop efficient platforms that are capable of accurately quantifying
responses of multiplex genetic perturbations while modeling the complex organization
of human cells.
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